| 1 |
Panattoni A, Calvigioni M, Benvenuti L, D'Antongiovanni V, Pellegrini C, Di Salvo C, Mazzantini D, Celandroni F, Fornai M, Antonioli L, Ghelardi E. The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice. Front Microbiol 2022;13:1054097. [PMID: 36590404 DOI: 10.3389/fmicb.2022.1054097] [Reference Citation Analysis]
|
| 2 |
Wan C, Kong X, Liao Y, Chen Q, Chen M, Ding Q, Liu X, Zhong W, Xu C, Liu W, Wang B. Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00971-5] [Reference Citation Analysis]
|
| 3 |
Liu Z, Li H, Gao D, Su J, Su Y, Ma Z, Li Z, Qi Y, Ding G. Microbial diversity of milk ghee in southern Gansu and its effect on the formation of ghee flavor compounds. Open Life Sci 2022;17:1629-40. [PMID: 36567720 DOI: 10.1515/biol-2022-0516] [Reference Citation Analysis]
|
| 4 |
Martin Z, Spry G, Hoult J, Maimone IR, Tang X, Crichton M, Marshall S. What is the efficacy of dietary, nutraceutical, and probiotic interventions for the management of gastroesophageal reflux disease symptoms? A systematic literature review and meta-analysis. Clin Nutr ESPEN 2022;52:340-52. [PMID: 36513474 DOI: 10.1016/j.clnesp.2022.09.015] [Reference Citation Analysis]
|
| 5 |
Wan C, Kong X, Liao Y, Chen Q, Chen M, Ding Q, Liu X, Zhong W, Xu C, Liu W, Wang B. Bibliometric analysis of the 100 most cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021.. [DOI: 10.21203/rs.3.rs-2250626/v1] [Reference Citation Analysis]
|
| 6 |
Wang Y, Chen N, Niu F, Li Y, Guo K, Shang X, E F, Yang C, Yang K, Li X. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs. Int J Colorectal Dis 2022. [PMID: 36251040 DOI: 10.1007/s00384-022-04261-0] [Reference Citation Analysis]
|
| 7 |
Ricci C, Rizzello F, Valerii MC, Spisni E, Gionchetti P, Turroni S, Candela M, D'Amico F, Spigarelli R, Bellocchio I, Marasco G, Barbara G. Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial. Nutrients 2022;14:4208. [PMID: 36235860 DOI: 10.3390/nu14194208] [Reference Citation Analysis]
|
| 8 |
Hershko-moshe A, Hasin Y, Nevo-shor A, Etzion O, Ilan Y. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance. GastroHep 2022;2022:1-12. [DOI: 10.1155/2022/1192547] [Reference Citation Analysis]
|
| 9 |
Siddiqui R, Mungroo MR, Alharbi AM, Alfahemi H, Khan NA. The Use of Gut Microbial Modulation Strategies as Interventional Strategies for Ageing. Microorganisms 2022;10:1869. [PMID: 36144471 DOI: 10.3390/microorganisms10091869] [Reference Citation Analysis]
|
| 10 |
Hadjimbei E, Botsaris G, Chrysostomou S. Beneficial Effects of Yoghurts and Probiotic Fermented Milks and Their Functional Food Potential. Foods 2022;11:2691. [PMID: 36076876 DOI: 10.3390/foods11172691] [Reference Citation Analysis]
|
| 11 |
Qu Q, Zhao C, Yang C, Zhou Q, Liu X, Yang P, Yang F, Shi X. Limosilactobacillus fermentum-fermented ginseng improved antibiotic-induced diarrhoea and the gut microbiota profiles of rats. J Appl Microbiol 2022. [PMID: 35965438 DOI: 10.1111/jam.15780] [Reference Citation Analysis]
|
| 12 |
Bergamini CM, Bianchi N, Giaccone V, Catellani P, Alberghini L, Stella A, Biffani S, Yaddehige SK, Bobbo T, Taccioli C. Machine Learning Algorithms Highlight tRNA Information Content and Chargaff’s Second Parity Rule Score as Important Features in Discriminating Probiotics from Non-Probiotics. Biology 2022;11:1024. [DOI: 10.3390/biology11071024] [Reference Citation Analysis]
|
| 13 |
Amieva-balmori M, García-mazcorro J, Martínez-conejo A, Hernández-ramírez G, García-zermeño K, Rodríguez-aguilera O, Aja-cadena M, Barradas-cortés M, Quigley E, Remes-troche J. Fecal bacterial microbiota in constipated patients before and after eight weeks of daily Bifidobacterium infantis 35624 administration. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.06.014] [Reference Citation Analysis]
|
| 14 |
Laroute V, Beaufrand C, Gomes P, Nouaille S, Tondereau V, Daveran-Mingot ML, Theodorou V, Eutamene H, Mercier-Bonin M, Cocaign-Bousquet M. Lactococcus lactis NCDO2118 exerts visceral antinociceptive properties in rat via GABA production in the gastro-intestinal tract. Elife 2022;11:e77100. [PMID: 35727704 DOI: 10.7554/eLife.77100] [Reference Citation Analysis]
|
| 15 |
Mehra Y, Rajesh NG, Viswanathan P. Analysis and Characterization of Lactobacillus paragasseri and Lacticaseibacillus paracasei: Two Probiotic Bacteria that Can Degrade Intestinal Oxalate in Hyperoxaluric Rats. Probiotics Antimicrob Proteins 2022. [PMID: 35699895 DOI: 10.1007/s12602-022-09958-w] [Reference Citation Analysis]
|
| 16 |
Michels M, Jesus GFA, Abatti MR, Córneo E, Cucker L, de Medeiros Borges H, da Silva Matos N, Rocha LB, Dias R, Simon CS, Voytena APL, Rossetto M, Ramlov F, Dal-Pizzol F. Effects of different probiotic strains B. lactis, L. rhamnosus and L. reuteri on brain-intestinal axis immunomodulation in an endotoxin-induced inflammation. Mol Neurobiol 2022. [PMID: 35674863 DOI: 10.1007/s12035-022-02906-3] [Reference Citation Analysis]
|
| 17 |
Amieva-balmori M, García-mazcorro J, Martínez-conejo A, Hernández-ramírez G, García-zermeño K, Rodríguez-aguilera O, Aja-cadena M, Cortes-barradas M, Quigley E, Remes-troche J. La microbiota bacteriana fecal en pacientes estreñidos previa y posterior a ocho semanas de administración diaria de Bifidobacterium infantis 35624. Revista de Gastroenterología de México 2022. [DOI: 10.1016/j.rgmx.2022.04.005] [Reference Citation Analysis]
|
| 18 |
Miryan M, Soleimani D, Alavinejad P, Abbaspour M, Ostadrahimi A. Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS-C) and mixed (IBS-M) stool pattern: A randomized, double-blind clinical trial. Food Sci Nutr 2022;10:1899-907. [PMID: 35702280 DOI: 10.1002/fsn3.2806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Maev IV, Andreev DN, Zaborovsky AV, Lobanova EG. Functional gastrointestinal diseases: mechanisms of development and principles of multitarget therapy. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-7-8-14] [Reference Citation Analysis]
|
| 20 |
Takáčová M, Bomba A, Tóthová C, Micháľová A, Turňa H. Any Future for Faecal Microbiota Transplantation as a Novel Strategy for Gut Microbiota Modulation in Human and Veterinary Medicine? Life 2022;12:723. [DOI: 10.3390/life12050723] [Reference Citation Analysis]
|
| 21 |
Storr M. Therapie-Update Reizdarmsyndrom. Gastro-News 2022;9:30-35. [DOI: 10.1007/s15036-022-2471-9] [Reference Citation Analysis]
|
| 22 |
Zhang T, Gao G, Sakandar HA, Kwok L, Sun Z. Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target. Front Nutr 2022;9:814269. [DOI: 10.3389/fnut.2022.814269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Chen YM, Li Y, Wang X, Wang ZL, Hou JJ, Su S, Zhong WL, Xu X, Zhang J, Wang BM, Wang YM. Effect of Bacillus subtilis, Enterococcus faecium, and Enterococcus faecalis supernatants on serotonin transporter expression in cells and tissues. World J Gastroenterol 2022; 28(5): 532-546 [DOI: 10.3748/wjg.v28.i5.532] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Kang SR, Nguyen DH, Yoo SW, Min JJ. Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Adv Drug Deliv Rev 2022;181:114085. [PMID: 34933064 DOI: 10.1016/j.addr.2021.114085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 25 |
Gueniche A, Liboutet M, Cheilian S, Fagot D, Juchaux F, Breton L. Vitreoscilla filiformis Extract for Topical Skin Care: A Review. Front Cell Infect Microbiol 2021;11:747663. [PMID: 34976852 DOI: 10.3389/fcimb.2021.747663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Sharma A, Wakode S, Sharma S, Fayaz F. Role of Gut Microbiota and Probiotic in Chronic Fatigue Syndrome. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-6760-2_9] [Reference Citation Analysis]
|
| 27 |
Wang Z, Yang B. Polypharmacology in Clinical Applications: Gastrointestinal Polypharmacology. Polypharmacology 2022. [DOI: 10.1007/978-3-031-04998-9_8] [Reference Citation Analysis]
|
| 28 |
Kunitake H, Staller K. Functional Disorders After Colorectal Surgery/IBS. The ASCRS Textbook of Colon and Rectal Surgery 2022. [DOI: 10.1007/978-3-030-66049-9_56] [Reference Citation Analysis]
|
| 29 |
Singh RP, Shadan A, Ma Y. Biotechnological Applications of Probiotics: A Multifarious Weapon to Disease and Metabolic Abnormality. Probiotics Antimicrob Proteins 2022;14:1184-210. [PMID: 36121610 DOI: 10.1007/s12602-022-09992-8] [Reference Citation Analysis]
|
| 30 |
Kim N. Irritable Bowel Syndrome. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_16] [Reference Citation Analysis]
|
| 31 |
Guslandi M. Probiotics and intestinal health. Probiotics 2022. [DOI: 10.1016/b978-0-323-85170-1.00013-0] [Reference Citation Analysis]
|
| 32 |
Aktas B. Gut Microbiota Dysbiosis and COVID-19: Possible Links. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00072-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Dibba P, Kothari M, Grosman I. Prebiotics, Probiotics, and Dietary Supplements. Nutrition, Weight, and Digestive Health 2022. [DOI: 10.1007/978-3-030-94953-2_11] [Reference Citation Analysis]
|
| 34 |
Abraham N, Namachivayam C, Sundaramoorthy S. Lactobacillus- An friendly Bacteria. IJT. [DOI: 10.52711/2231-3915.2021.00010] [Reference Citation Analysis]
|
| 35 |
Ayyash M, Al-najjar MAA, Jaber K, Ayyash L, Abu-farha R. Assessment of public knowledge and perception about the use of probiotics. European Journal of Integrative Medicine 2021;48:101404. [DOI: 10.1016/j.eujim.2021.101404] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 36 |
Dos Santos CI, Campos CDL, Nunes-Neto WR, do Carmo MS, Nogueira FAB, Ferreira RM, Costa EPS, Gonzaga LF, Araújo JMM, Monteiro JM, Monteiro CRAV, Platner FS, Figueiredo IFS, Holanda RA, Monteiro SG, Fernandes ES, Monteiro AS, Monteiro-Neto V. Genomic Analysis of Limosilactobacillus fermentum ATCC 23271, a Potential Probiotic Strain with Anti-Candida Activity. J Fungi (Basel) 2021;7:794. [PMID: 34682216 DOI: 10.3390/jof7100794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 37 |
van Zyl WF, Deane SM, Dicks LMT. Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria. Gut Microbes 2020;12:1831339. [PMID: 33112695 DOI: 10.1080/19490976.2020.1831339] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 38 |
Naseer M, Poola S, Uraz S, Tahan V. Therapeutic Effects of Prebiotics on Constipation: A Schematic Review. Curr Clin Pharmacol 2020;15:207-15. [PMID: 32048977 DOI: 10.2174/1574884715666200212125035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 39 |
Khlinov IB, Khlynova RI, Voronova EI, Garanina EV, Gurikova IA, Kobzar TI, Loseva ME, Odinets SV, Ryabinina OA, Sagutdinova LT, Freze EB. Efficacy and safety of Lactobacillus paracasei CNCM I-1572 and fructo- oligosaccharides in the treatment of patients with irritable bowel syndrome with constipation. jour 2021;1:57-62. [DOI: 10.31146/1682-8658-ecg-190-6-57-62] [Reference Citation Analysis]
|
| 40 |
Ansari F, Alian Samakkhah S, Bahadori A, Jafari SM, Ziaee M, Khodayari MT, Pourjafar H. Health-promoting properties of Saccharomyces cerevisiae var. boulardii as a probiotic; characteristics, isolation, and applications in dairy products. Crit Rev Food Sci Nutr 2023;63:457-85. [PMID: 34254862 DOI: 10.1080/10408398.2021.1949577] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 41 |
Pratt C, Campbell MD. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Probiotics Antimicrob Proteins 2020;12:834-9. [PMID: 31741311 DOI: 10.1007/s12602-019-09609-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 42 |
Iida M, Desamero MJ, Yasuda K, Nakashima A, Suzuki K, Chambers JK, Uchida K, Ogawa R, Hachimura S, Nakayama J, Kyuwa S, Miura K, Kakuta S, Hirayama K. Effects of orally administered Euglena gracilis and its reserve polysaccharide, paramylon, on gastric dysplasia in A4gnt knockout mice. Sci Rep 2021;11:13640. [PMID: 34210998 DOI: 10.1038/s41598-021-92013-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Chung HG, Min YW, Lee C, Hong SN, Won JY, Jang JA, Kim CH, Chang DK. Effects of Novel Probiotics in a Murine Model of Irritable Bowel Syndrome. Korean J Gastroenterol 2020;75:141-6. [PMID: 32209802 DOI: 10.4166/kjg.2020.75.3.141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Abdullah N, Kueh YC, Kuan G, Wong MS, Yahaya FH, Abd Samat NA, Zulkifli KK, Lee YY. Development and validation of the Health Promoting Behaviour for Bloating (HPB-Bloat) scale. PeerJ 2021;9:e11444. [PMID: 34141467 DOI: 10.7717/peerj.11444] [Reference Citation Analysis]
|
| 45 |
Ivashkin VT, Maev IV, Abdulganieva DI, Alekseenko SA, Gorelov AV, Zakharova IN, Zolnikova OY, Ivashkina NY, Korochanskaya NV, Mammayev SN, Poluektova EA, Trukhmanov AS, Usenko DV, Uspensky YP, Tsukanov VV, Shifrin OS, Berezhnaya IV, Ivashkin KV, Lapina TL, Maslennikov RV, Nikolaeva SV, Sugyan NG, Ulyanin AI. Practical Recommendations of Scientific Society for the Study of Human Microbiome and the Russian Gastroenterological Association on Use of Probiotics, Prebiotics, Synbiotics and Functional Foods in Treatment and Prevention of Gastroenterological Diseases in Children and Adults. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2021;31:65-91. [DOI: 10.22416/1382-4376-2021-31-2-65-91] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 46 |
Ryan JJ, Monteagudo-Mera A, Contractor N, Gibson GR. Impact of 2'-Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings. Nutrients 2021;13:938. [PMID: 33799455 DOI: 10.3390/nu13030938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 47 |
Barbuti RC, Schiavon LL, Oliveira CP, Alvares-DA-Silva MR, Sassaki LY, Passos MDCF, Farias AQ, Barros LL, Barreto BP, Albuquerque GBML, Alves AM, Navarro-Rodriguez T, Bittencourt PL. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arq Gastroenterol 2020;57:381-98. [PMID: 33331485 DOI: 10.1590/S0004-2803.202000000-72] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 48 |
Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, Sato K, Shiotani A, Naito Y, Fujikawa Y, Hokari R, Masaoka T, Fujimoto K, Kaneko H, Torii A, Matsueda K, Miwa H, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol 2021;56:193-217. [PMID: 33538894 DOI: 10.1007/s00535-020-01746-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 49 |
Bollom MA, Clark S, Acevedo NC. Edible lecithin, stearic acid, and whey protein bigels enhance survival of probiotics during in vitro digestion. Food Bioscience 2021;39:100813. [DOI: 10.1016/j.fbio.2020.100813] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 50 |
Zhang C, Zhang Y, Liu G, Li W, Xia S, Li H, Liu X. Effects of soybean protein isolates and peptides on the growth and metabolism of Lactobacillus rhamnosus. Journal of Functional Foods 2021;77:104335. [DOI: 10.1016/j.jff.2020.104335] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 51 |
Lee YY, Leow AH, Chai PF, Raja Ali RA, Lee WS, Goh KL. Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology. JGH Open 2021;5:11-9. [PMID: 33490608 DOI: 10.1002/jgh3.12469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 52 |
Davoodvandi A, Marzban H, Goleij P, Sahebkar A, Morshedi K, Rezaei S, Mahjoubin-Tehran M, Tarrahimofrad H, Hamblin MR, Mirzaei H. Effects of therapeutic probiotics on modulation of microRNAs. Cell Commun Signal 2021;19:4. [PMID: 33430873 DOI: 10.1186/s12964-020-00668-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 53 |
Frieling T, Keller J. Reizdarmsyndrom. Therapie-Handbuch - Gastroenterologie und Hepatologie 2021. [DOI: 10.1016/b978-3-437-23847-5.00023-5] [Reference Citation Analysis]
|
| 54 |
Savitri, Lata P. Probiotics for Human Health. Microorganisms for Sustainability 2021. [DOI: 10.1007/978-981-15-6795-7_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 55 |
Voss GB, Campos DA, Pintado MM. Cereal Bars Added With Probiotics and Prebiotics. Probiotics and Prebiotics in Foods 2021. [DOI: 10.1016/b978-0-12-819662-5.00009-4] [Reference Citation Analysis]
|
| 56 |
Shehata HR, Newmaster SG. Fraud in probiotic products. Food Fraud 2021. [DOI: 10.1016/b978-0-12-817242-1.00011-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Farmer AD, Wood E, Ruffle JK. An approach to the care of patients with irritable bowel syndrome. CMAJ 2020;192:E275-82. [PMID: 32179536 DOI: 10.1503/cmaj.190716] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 58 |
Li Q, Wan G, Peng C, Xu L, Yu Y, Li L, Li G. Effect of probiotic supplementation on growth performance, intestinal morphology, barrier integrity, and inflammatory response in broilers subjected to cyclic heat stress. Anim Sci J 2020;91:e13433. [PMID: 32671948 DOI: 10.1111/asj.13433] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 59 |
Bu F, Chen R, Lin Z, Cao H, Robinson N, Liang N, Liu J. Chinese herbal medicine versus probiotics for irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. European Journal of Integrative Medicine 2020;38:101177. [DOI: 10.1016/j.eujim.2020.101177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 60 |
Dixon A, Robertson K, Yung A, Que M, Randall H, Wellalagodage D, Cox T, Robertson D, Chi C, Sun J. Efficacy of Probiotics in Patients of Cardiovascular Disease Risk: a Systematic Review and Meta-analysis. Curr Hypertens Rep 2020;22:74. [PMID: 32860083 DOI: 10.1007/s11906-020-01080-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 61 |
Miryan M, Alavinejad P, Abbaspour M, Soleimani D, Ostadrahimi A. Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial. Trials 2020;21:698. [PMID: 32758282 DOI: 10.1186/s13063-020-04615-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 62 |
Yang CQ, Guo XS, Ji-Li, Wei ZB, Zhao L, Zhao GT, Sheng ST. Rifaximin Improves Visceral Hyperalgesia via TRPV1 by Modulating Intestinal Flora in the Water Avoidance Stressed Rat. Gastroenterol Res Pract 2020;2020:4078681. [PMID: 32765600 DOI: 10.1155/2020/4078681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 63 |
Wen Y, Li J, Long Q, Yue C, He B, Tang X. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials. International Journal of Surgery 2020;79:111-9. [DOI: 10.1016/j.ijsu.2020.04.063] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 64 |
Shehata HR, Newmaster SG. Combined Targeted and Non-targeted PCR Based Methods Reveal High Levels of Compliance in Probiotic Products Sold as Dietary Supplements in United States and Canada. Front Microbiol 2020;11:1095. [PMID: 32582075 DOI: 10.3389/fmicb.2020.01095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 65 |
Liang T, Wu L, Xi Y, Li Y, Xie X, Fan C, Yang L, Yang S, Chen X, Zhang J, Wu Q. Probiotics supplementation improves hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes mellitus: An update of meta-analysis. Crit Rev Food Sci Nutr 2021;61:1670-88. [PMID: 32436397 DOI: 10.1080/10408398.2020.1764488] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 66 |
Chondrou P, Karapetsas A, Kiousi DE, Vasileiadis S, Ypsilantis P, Botaitis S, Alexopoulos A, Plessas S, Bezirtzoglou E, Galanis A. Assessment of the Immunomodulatory Properties of the Probiotic Strain Lactobacillus paracasei K5 in vitro and In Vivo. Microorganisms 2020;8:E709. [PMID: 32403327 DOI: 10.3390/microorganisms8050709] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 67 |
Ivashkin VT, Mayev IV, Abdulganieva DI, Alekseenko SA, Ivashkina NY, Korochanskaya NV, Mammaev SN, Poluektova EA, Trukhmanov AS, Uspensky YP, Tsukanov VV, Shifrin OS, Zolnikova OY, Ivashkin KV, Lapina TL, Maslennikov RV, Ulyanin AI. Practical Recommendations of Scientific Society for the Study of Human Microbiome and Russian Gastroenterological Association (RGA) for Probiotics in Treatment and Prevention of Gastroenterological Diseases in Adults. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2020;30:76-89. [DOI: 10.22416/1382-4376-2020-30-2-76-89] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 68 |
Agah S, Akbari A, Heshmati J, Sepidarkish M, Morvaridzadeh M, Adibi P, Mazidi M, Farsi F, Ofori-asenso R, Talley NJ, Feinle-bisset C. Systematic review with meta-analysis: Effects of probiotic supplementation on symptoms in functional dyspepsia. Journal of Functional Foods 2020;68:103902. [DOI: 10.1016/j.jff.2020.103902] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 69 |
Ismail S, Ahmad S, Azam SS. Vaccinomics to design a novel single chimeric subunit vaccine for broad-spectrum immunological applications targeting nosocomial Enterobacteriaceae pathogens. European Journal of Pharmaceutical Sciences 2020;146:105258. [DOI: 10.1016/j.ejps.2020.105258] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 70 |
Hug JJ, Krug D, Müller R. Bacteria as genetically programmable producers of bioactive natural products. Nat Rev Chem 2020;4:172-93. [DOI: 10.1038/s41570-020-0176-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 71 |
Mari A, Abu Baker F, Mahamid M, Sbeit W, Khoury T. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. J Clin Med 2020;9:E685. [PMID: 32143424 DOI: 10.3390/jcm9030685] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 72 |
Gao R, Zhang X, Huang L, Shen R, Qin H. Gut Microbiota Alteration After Long-Term Consumption of Probiotics in the Elderly. Probiotics Antimicrob Proteins 2019;11:655-66. [PMID: 29520675 DOI: 10.1007/s12602-018-9403-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 73 |
Niu H, Xiao J. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials. International Journal of Surgery 2020;75:116-27. [DOI: 10.1016/j.ijsu.2020.01.142] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 74 |
Bu F, Wang W, Chen R, Lin Z, Han M, Robinson N, Liu X, Lu C, Liu J. Adding Chinese herbal medicine to probiotics for irritable bowel syndrome-diarrhea: A systematic review and meta-analysis of randomized controlled trials. Journal of Traditional Chinese Medical Sciences 2020;7:20-36. [DOI: 10.1016/j.jtcms.2020.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 75 |
Gao J, Azad MAK, Han H, Wan D, Li T. Impact of Prebiotics on Enteric Diseases and Oxidative Stress. Curr Pharm Des 2020;26:2630-41. [PMID: 32066357 DOI: 10.2174/1381612826666200211121916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 76 |
Li Y, Yin Z, Zhang Y, Liu J, Cheng Y, Wang J, Pi F, Zhang Y, Sun X. Perspective of Microbe-based Minerals Fortification in Nutrition Security. Food Reviews International 2022;38:268-81. [DOI: 10.1080/87559129.2020.1728308] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 77 |
Shavandi A, Saeedi P, Gérard P, Jalalvandi E, Cannella D, Bekhit AE. The role of microbiota in tissue repair and regeneration. J Tissue Eng Regen Med 2020;14:539-55. [PMID: 31845514 DOI: 10.1002/term.3009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 78 |
Rossi G, Gioacchini G, Pengo G, Suchodolski JS, Jergens AE, Allenspach K, Gavazza A, Scarpona S, Berardi S, Galosi L, Bassotti G, Cerquetella M. Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes. Neurogastroenterol Motil 2020;32:e13717. [PMID: 31495983 DOI: 10.1111/nmo.13717] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 79 |
Koerner CP, Sullivan PS. Colonic Conditions: Irritable Bowel Syndrome (IBS). Clinical Decision Making in Colorectal Surgery 2020. [DOI: 10.1007/978-3-319-65942-8_50] [Reference Citation Analysis]
|
| 80 |
Zielińska A. Pain in irritable bowel syndrome. A Comprehensive Overview of Irritable Bowel Syndrome 2020. [DOI: 10.1016/b978-0-12-821324-7.00010-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 81 |
El-dalatony MM, El-sheekh M, Li X. Environmental Pollutants that Can Be Metabolized by the Host, but Would Be Harmful to Humans (e.g., Causing Cancers, etc.). Gut Remediation of Environmental Pollutants 2020. [DOI: 10.1007/978-981-15-4759-1_6] [Reference Citation Analysis]
|
| 82 |
Flethes CG, Gallego SKVYMG. Protocolo diagnóstico y terapéutico de la distensión abdominal recurrente. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:53-58. [DOI: 10.1016/j.med.2020.01.008] [Reference Citation Analysis]
|
| 83 |
De Angelis M, Garruti G, Minervini F, Bonfrate L, Portincasa P, Gobbetti M. The Food-gut Human Axis: The Effects of Diet on Gut Microbiota and Metabolome. Curr Med Chem. 2019;26:3567-3583. [PMID: 28462705 DOI: 10.2174/0929867324666170428103848] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 84 |
Oh JH, Jang YS, Kang D, Chang DK, Min YW. Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2019;11. [PMID: 31783597 DOI: 10.3390/nu11122887] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 85 |
Hawrelak JA, Wohlmuth H, Pattinson M, Myers SP, Goldenberg JZ, Harnett J, Cooley K, Van De Venter C, Reid R, Whitten DL. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Complement Ther Med 2020;48:102233. [PMID: 31987249 DOI: 10.1016/j.ctim.2019.102233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 86 |
Al-Zyoud W, Nasereddin A, Aljarajrah H, Saket M. Culturable gut bacteria lack Escherichia coli in children with phenylketonuria. New Microbes New Infect 2019;32:100616. [PMID: 31763047 DOI: 10.1016/j.nmni.2019.100616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 87 |
Yus C, Gracia R, Larrea A, Andreu V, Irusta S, Sebastian V, Mendoza G, Arruebo M. Targeted Release of Probiotics from Enteric Microparticulated Formulations. Polymers (Basel) 2019;11:E1668. [PMID: 31614915 DOI: 10.3390/polym11101668] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 88 |
Baritaki S, de Bree E, Chatzaki E, Pothoulakis C. Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk. J Clin Med 2019;8:E1669. [PMID: 31614860 DOI: 10.3390/jcm8101669] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 89 |
Defaye M, Gervason S, Altier C, Berthon JY, Ardid D, Filaire E, Carvalho FA. Microbiota: a novel regulator of pain. J Neural Transm (Vienna) 2020;127:445-65. [PMID: 31552496 DOI: 10.1007/s00702-019-02083-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 90 |
Aleixandre-tudó JL, Castelló-cogollos L, Aleixandre JL, Aleixandre-benavent R. Tendencies and Challenges in Worldwide Scientific Research on Probiotics. Probiotics & Antimicro Prot 2020;12:785-97. [DOI: 10.1007/s12602-019-09591-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 91 |
Eskandarzadeh S, Effatpanah M, Khosravi-Darani K, Askari R, Hosseini AF, Reisian M, Jazayeri S. Efficacy of a multispecies probiotic as adjunctive therapy in generalized anxiety disorder: a double blind, randomized, placebo-controlled trial. Nutr Neurosci 2021;24:102-8. [PMID: 31516094 DOI: 10.1080/1028415X.2019.1598669] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 92 |
Cornacchione LP, Klein BA, Duncan MJ, Hu LT. Interspecies Inhibition of Porphyromonas gingivalis by Yogurt-Derived Lactobacillus delbrueckii Requires Active Pyruvate Oxidase. Appl Environ Microbiol 2019;85:e01271-19. [PMID: 31285191 DOI: 10.1128/AEM.01271-19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 93 |
Liu J, Wu M, He J, Xiao C, Xue Y, Fu T, Lin C, Dong D, Li Z. Antibiotic-Induced Dysbiosis of Gut Microbiota Impairs Corneal Nerve Regeneration by Affecting CCR2-Negative Macrophage Distribution. Am J Pathol 2018;188:2786-99. [PMID: 30470496 DOI: 10.1016/j.ajpath.2018.08.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 94 |
Ross SM. Gut-Brain Axis and Stress Regulation: Effects of Probiotics on Neurocognition. Holist Nurs Pract 2019;33:312-5. [PMID: 31415011 DOI: 10.1097/HNP.0000000000000346] [Reference Citation Analysis]
|
| 95 |
Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2019;4:675-685. [PMID: 31326345 DOI: 10.1016/s2468-1253(19)30198-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 96 |
Jensen AP, Bjørnvad CR. Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review. J Vet Intern Med 2019;33:1849-64. [PMID: 31313372 DOI: 10.1111/jvim.15554] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 97 |
Valdovinos-garcía L, Abreu A, Valdovinos-díaz M. Probiotic use in clinical practice: Results of a national survey of gastroenterologists and nutritionists. Revista de Gastroenterología de México (English Edition) 2019;84:303-9. [DOI: 10.1016/j.rgmxen.2018.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 98 |
Tavakoli A, Flanagan JL. The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics? Antibiotics (Basel) 2019;8:E88. [PMID: 31262073 DOI: 10.3390/antibiotics8030088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 99 |
Bruno G, Zaccari P, Rocco G, Scalese G, Panetta C, Porowska B, Pontone S, Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 2019; 25(22): 2706-2719 [PMID: 31235994 DOI: 10.3748/wjg.v25.i22.2706] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 93] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 100 |
Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med 2019;25:716-29. [DOI: 10.1038/s41591-019-0439-x] [Cited by in Crossref: 405] [Cited by in F6Publishing: 421] [Article Influence: 101.3] [Reference Citation Analysis]
|
| 101 |
Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply. Aliment Pharmacol Ther 2019;49:1254-5. [PMID: 30977174 DOI: 10.1111/apt.15234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 102 |
Mari A, Abu Backer F, Mahamid M, Amara H, Carter D, Boltin D, Dickman R. Bloating and Abdominal Distension: Clinical Approach and Management. Adv Ther 2019;36:1075-84. [PMID: 30879252 DOI: 10.1007/s12325-019-00924-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 103 |
Chakravarty K, Gaur S. Role of Probiotics in Prophylaxis of Helicobacter pylori Infection. CPB 2019;20:137-45. [DOI: 10.2174/1389201020666190227203107] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 104 |
Suez J, Zmora N, Elinav E. Probiotics in the next-generation sequencing era. Gut Microbes 2020;11:77-93. [PMID: 30951391 DOI: 10.1080/19490976.2019.1586039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 105 |
Le Nevé B, Derrien M, Tap J, Brazeilles R, Cools Portier S, Guyonnet D, Ohman L, Störsrud S, Törnblom H, Simrén M. Fasting breath H2 and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome. PLoS One 2019;14:e0214273. [PMID: 30946757 DOI: 10.1371/journal.pone.0214273] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 106 |
Yu LM, Zhao KJ, Wang SS, Wang X, Lu B. Corticotropin-releasing factor induces inflammatory cytokines via the NLRP6-inflammatory cytokine axis in a murine model of irritable bowel syndrome. J Dig Dis 2019;20:143-51. [PMID: 30663229 DOI: 10.1111/1751-2980.12704] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 107 |
Maia LP, Levi YLDAS, do Prado RL, Santinoni CDS, Marsicano JA. Effects of probiotic therapy on serum inflammatory markers: A systematic review and meta-analysis. Journal of Functional Foods 2019;54:466-78. [DOI: 10.1016/j.jff.2019.01.051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 108 |
Capurso L. Thirty Years of Lactobacillus rhamnosus GG: A Review. J Clin Gastroenterol 2019;53 Suppl 1:S1-S41. [PMID: 30741841 DOI: 10.1097/MCG.0000000000001170] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 29.0] [Reference Citation Analysis]
|
| 109 |
Trukhan DI, Goloshubina VV, Ivanova DS. Actual issues of diagnosis and treatment of irritable bowel syndrome. Med sov 2019. [DOI: 10.21518/2079-701x-2018-21-110-116] [Reference Citation Analysis]
|
| 110 |
Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of Action of Probiotics. Adv Nutr 2019;10:S49-66. [PMID: 30721959 DOI: 10.1093/advances/nmy063] [Cited by in Crossref: 359] [Cited by in F6Publishing: 385] [Article Influence: 89.8] [Reference Citation Analysis]
|
| 111 |
Li H, Fang Z. Lactic Acid Bacteria and Gut Health. Lactic Acid Bacteria 2019. [DOI: 10.1007/978-981-13-7832-4_8] [Reference Citation Analysis]
|
| 112 |
Riva A, Giacomelli L, Togni S, Franceschi F, Eggenhoffner R, Zuccarini MC, Belcaro G. Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.18.02530-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 113 |
Machado Prado MR, Boller C. Anti-inflammatory effects of probiotics. Discovery and Development of Anti-Inflammatory Agents from Natural Products 2019. [DOI: 10.1016/b978-0-12-816992-6.00009-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 114 |
Liu JM, Zhao N, Wang ZH, Lv SW, Li CY, Wang S. In-Taken Labeling and in Vivo Tracing Foodborne Probiotics via DNA-Encapsulated Persistent Luminescence Nanoprobe Assisted Autofluorescence-Free Bioimaging. J Agric Food Chem 2019;67:514-9. [PMID: 30563334 DOI: 10.1021/acs.jafc.8b05937] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 115 |
Alammar N, Stein E. Irritable Bowel Syndrome: What Treatments Really Work. Med Clin North Am. 2019;103:137-152. [PMID: 30466670 DOI: 10.1016/j.mcna.2018.08.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 116 |
Khlevner J, Park Y, Margolis KG. Brain-Gut Axis: Clinical Implications. Gastroenterol Clin North Am 2018;47:727-39. [PMID: 30337029 DOI: 10.1016/j.gtc.2018.07.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 117 |
Villageliú D, Lyte M. Dopamine production in Enterococcus faecium: A microbial endocrinology-based mechanism for the selection of probiotics based on neurochemical-producing potential. PLoS One 2018;13:e0207038. [PMID: 30485295 DOI: 10.1371/journal.pone.0207038] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 118 |
Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2018;48:1044-60. [PMID: 30294792 DOI: 10.1111/apt.15001] [Cited by in Crossref: 251] [Cited by in F6Publishing: 275] [Article Influence: 50.2] [Reference Citation Analysis]
|
| 119 |
Rawla P, Sunkara T, Raj JP. Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome. Life Sciences 2018;212:176-81. [DOI: 10.1016/j.lfs.2018.10.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 120 |
Karakan T. Gut microbiata: underestimated or exaggerated? Mucosa 2018;1:30-35. [DOI: 10.33204/mucosa.476149] [Reference Citation Analysis]
|
| 121 |
Liu Y, Alookaran JJ, Rhoads JM. Probiotics in Autoimmune and Inflammatory Disorders. Nutrients 2018;10:E1537. [PMID: 30340338 DOI: 10.3390/nu10101537] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 122 |
Kim YS, Kim N. Sex-Gender Differences in Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018;24:544-558. [PMID: 30347934 DOI: 10.5056/jnm18082] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 123 |
Ghattargi VC, Kalam SH, Pandit SS, Pawar SP, Shouche YS. Survey of probiotic preparations and labeling practices in Indian market. Indian J Med Microbiol 2018;36:116-8. [PMID: 29735839 DOI: 10.4103/ijmm.IJMM_18_63] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 124 |
Moser AM, Spindelboeck W, Halwachs B, Strohmaier H, Kump P, Gorkiewicz G, Högenauer C. Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome. Eur J Nutr 2019;58:2767-78. [PMID: 30251020 DOI: 10.1007/s00394-018-1826-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 125 |
Chang C. Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin. Clin Exp Gastroenterol 2018;11:335-45. [PMID: 30288076 DOI: 10.2147/CEG.S167031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 126 |
Cremon C, Barbaro MR, Ventura M, Barbara G. Pre- and probiotic overview. Curr Opin Pharmacol. 2018;43:87-92. [PMID: 30219638 DOI: 10.1016/j.coph.2018.08.010] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 127 |
Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 2018;356:413-23. [PMID: 30384950 DOI: 10.1016/j.amjms.2018.08.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 128 |
Fukui H, Oshima T, Tanaka Y, Oikawa Y, Makizaki Y, Ohno H, Tomita T, Watari J, Miwa H. Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats. Sci Rep 2018;8:12384. [PMID: 30120330 DOI: 10.1038/s41598-018-30943-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 129 |
Fukui H, Xu X, Miwa H. Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. J Neurogastroenterol Motil 2018;24:367-86. [PMID: 29969855 DOI: 10.5056/jnm18071] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 130 |
Park C, Brietzke E, Rosenblat JD, Musial N, Zuckerman H, Ragguett RM, Pan Z, Rong C, Fus D, McIntyre RS. Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism? Brain Behav Immun 2018;73:115-24. [PMID: 30009996 DOI: 10.1016/j.bbi.2018.07.006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 131 |
Zielińska A, Sałaga M, Włodarczyk M, Fichna J. Chronic abdominal pain in irritable bowel syndrome - current and future therapies. Expert Rev Clin Pharmacol 2018;11:729-39. [PMID: 29957084 DOI: 10.1080/17512433.2018.1494571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 132 |
Valdovinos-García LR, Abreu AT, Valdovinos-Díaz MA. Probiotic use in clinical practice: Results of a national survey of gastroenterologists and nutritionists. Rev Gastroenterol Mex (Engl Ed) 2019;84:303-9. [PMID: 31383293 DOI: 10.1016/j.rgmx.2018.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 133 |
Salem AE, Singh R, Ayoub YK, Khairy AM, Mullin GE. The gut microbiome and irritable bowel syndrome: State of art review. Arab J Gastroenterol. 2018;19:136-141. [PMID: 29935865 DOI: 10.1016/j.ajg.2018.02.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 134 |
Sudha MR, Jayanthi N, Aasin M, Dhanashri R, Anirudh T. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study. Beneficial Microbes 2018;9:563-72. [DOI: 10.3920/bm2017.0129] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 135 |
Preston K, Krumian R, Hattner J, de Montigny D, Stewart M, Gaddam S. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.Benef Microbes. 2018;9:697-706. [PMID: 29888656 DOI: 10.3920/BM2017.0105] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 136 |
Song KH, Jung HK, Kim HJ, Koo HS, Kwon YH, Shin HD, Lim HC, Shin JE, Kim SE, Cho DH, Kim JH, Kim HJ; Clinical Practice Guidelines Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. J Neurogastroenterol Motil. 2018;24:197-215. [PMID: 29605976 DOI: 10.5056/jnm17145] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 137 |
Dossett ML, Cohen EM, Cohen J. Integrative Medicine for Gastrointestinal Disease. Prim Care 2017;44:265-80. [PMID: 28501229 DOI: 10.1016/j.pop.2017.02.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 138 |
Hungin APS, Mitchell CR, Whorwell P, Mulligan C, Cole O, Agréus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Seifert B, Wensaas KA, Winchester C, de Wit N; European Society for Primary Care Gastroenterology. Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus. Aliment Pharmacol Ther 2018;47:1054-70. [PMID: 29460487 DOI: 10.1111/apt.14539] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 139 |
Wu X, Xu W, Liu M, Hu K, Sun Y, Yang X, Zhu G, Wang Z, Huang W. Efficacy of prophylactic probiotics in combination with antibiotics versus antibiotics alone for colorectal surgery: A meta-analysis of randomized controlled trials. J Surg Oncol 2018;117:1394-404. [DOI: 10.1002/jso.25038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 140 |
Aramă Ș. Irritable bowel syndrome and probiotics place in therapeutic strategies. Infectio ro 2018;56 (4):9-21. [DOI: 10.26416/inf.56.4.2018.2188] [Reference Citation Analysis]
|
| 141 |
Bibliographie. Alimentation santé 2018. [DOI: 10.3917/dunod.brenn.2018.01.0283] [Reference Citation Analysis]
|
| 142 |
Kumar N, Kumari V, Ram C, Thakur K, Tomar SK. Bio-prospectus of cadmium bioadsorption by lactic acid bacteria to mitigate health and environmental impacts. Appl Microbiol Biotechnol 2018;102:1599-615. [PMID: 29352397 DOI: 10.1007/s00253-018-8743-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 143 |
Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic G, Zivkovic V. Irritable bowel syndrome - from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018;162:1-9. [PMID: 29358788 DOI: 10.5507/bp.2017.057] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 144 |
Henningsen P, Zipfel S, Sattel H, Creed F. Management of Functional Somatic Syndromes and Bodily Distress. Psychother Psychosom 2018;87:12-31. [DOI: 10.1159/000484413] [Cited by in Crossref: 114] [Cited by in F6Publishing: 120] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 145 |
Hidalgo-cantabrana C, Delgado S, Ruiz L, Ruas-madiedo P, Sánchez B, Margolles A. Bifidobacteria and Their Health-Promoting Effects. Bugs as Drugs 2018. [DOI: 10.1128/9781555819705.ch3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 146 |
Bharucha AE, Brookes SJ. Neurophysiologic Mechanisms of Human Large Intestinal Motility ☆. Physiology of the Gastrointestinal Tract 2018. [DOI: 10.1016/b978-0-12-809954-4.00023-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 147 |
de Jongh TOH. Chronische buikpijn (PDS). Therapie van alledaagse klachten 2018. [DOI: 10.1007/978-90-368-1922-0_22] [Reference Citation Analysis]
|
| 148 |
Barrett B. Viral Upper Respiratory Infection. Integrative Medicine 2018. [DOI: 10.1016/b978-0-323-35868-2.00018-9] [Cited by in Crossref: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 149 |
Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect 2018;76:111-20. [PMID: 29291933 DOI: 10.1016/j.jinf.2017.12.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 150 |
Lee JY, Kim N, Nam RH, Sohn SH, Lee SM, Choi D, Yoon H, Kim YS, Lee HS, Lee DH. Probiotics reduce repeated water avoidance stress-induced colonic microinflammation in Wistar rats in a sex-specific manner. PLoS One 2017;12:e0188992. [PMID: 29244820 DOI: 10.1371/journal.pone.0188992] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 151 |
Chen Q, Ren Y, Lu J, Bartlett M, Chen L, Zhang Y, Guo X, Liu C. A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome in Mice by Improving Gut Microbiota and Modulating Immune Response. Nutrients 2017;9:E1341. [PMID: 29232851 DOI: 10.3390/nu9121341] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 152 |
Joly F, Nuzzo A, Kapel N, Thomas M. Lien entre les probiotiques et le microbiote : vision du clinicien. Cahiers de Nutrition et de Diététique 2017;52:S5-S12. [DOI: 10.1016/s0007-9960(17)30193-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 153 |
Schatz RA, Moshiree B. Gastrointestinal and Hepatic Disease in Fibromyalgia. Rheum Dis Clin North Am 2018;44:131-42. [PMID: 29149921 DOI: 10.1016/j.rdc.2017.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 154 |
Zoumpopoulou G, Tsakalidou E, Thomas L. An Overview of Probiotic Research. Probiotic Dairy Products 2017. [DOI: 10.1002/9781119214137.ch8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 155 |
Pérez-Berezo T, Pujo J, Martin P, Le Faouder P, Galano JM, Guy A, Knauf C, Tabet JC, Tronnet S, Barreau F, Heuillet M, Dietrich G, Bertrand-Michel J, Durand T, Oswald E, Cenac N. Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917. Nat Commun 2017;8:1314. [PMID: 29101366 DOI: 10.1038/s41467-017-01403-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 156 |
Cremon C, Guglielmetti S, Gargari G, Taverniti V, Castellazzi AM, Valsecchi C, Tagliacarne C, Fiore W, Bellini M, Bertani L, Gambaccini D, Cicala M, Germanà B, Vecchi M, Pagano I, Barbaro MR, Bellacosa L, Stanghellini V, Barbara G. Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial. United European Gastroenterol J 2018;6:604-13. [PMID: 29881616 DOI: 10.1177/2050640617736478] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 157 |
Allaire C, Aksoy T, Bedaiwy M, Britnell S, Noga HL, Yager H, Yong PJ. An Interdisciplinary Approach to Endometriosis-associated Persistent Pelvic Pain. Journal of Endometriosis and Pelvic Pain Disorders 2017;9:77-86. [DOI: 10.5301/jeppd.5000284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 158 |
Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 159 |
Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and Their Health-Promoting Effects. Microbiol Spectr 2017;5. [PMID: 28643627 DOI: 10.1128/microbiolspec.BAD-0010-2016] [Cited by in Crossref: 128] [Cited by in F6Publishing: 144] [Article Influence: 21.3] [Reference Citation Analysis]
|
| 160 |
Gately NM, Kennedy JE. The Development of a Melt-Extruded Shellac Carrier for the Targeted Delivery of Probiotics to the Colon. Pharmaceutics 2017;9:E38. [PMID: 28937621 DOI: 10.3390/pharmaceutics9040038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 161 |
McCarville JL, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray JA, Duboux S, Steinmann M, Delley M, Tangyu M, Langella P, Mercenier A, Bergonzelli G, Verdu EF. A Commensal Bifidobacterium longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor. Appl Environ Microbiol 2017;83:e01323-17. [PMID: 28778891 DOI: 10.1128/AEM.01323-17] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 162 |
Ohtsu T, Takagi A, Uemura N, Inoue K, Sekino H, Kawashima A, Uchida M, Koga Y. The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study. Digestion 2017;96:92-102. [PMID: 28768250 DOI: 10.1159/000479000] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 163 |
Draper K, Ley C, Parsonnet J. Probiotic guidelines and physician practice: a cross-sectional survey and overview of the literature. Beneficial Microbes 2017;8:507-19. [DOI: 10.3920/bm2016.0146] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 164 |
Winiarz D, Domańska K, Paluch K, Dorota Skrajnowska D. PROBIOTYKI A ZDROWIE - DZIŚ I JUTRO. pps 2017;15:86-94. [DOI: 10.56782/pps.82] [Reference Citation Analysis]
|
| 165 |
Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 166 |
Rai D, Rai G. Leveraging Bioactives to Support Human Health through the Lifecycle: Scientific Evidence and Regulatory Considerations. Functional Food - Improve Health through Adequate Food 2017. [DOI: 10.5772/intechopen.69836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 167 |
Hod K, Sperber AD, Ron Y, Boaz M, Dickman R, Berliner S, Halpern Z, Maharshak N, Dekel R. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS. Neurogastroenterol Motil 2017;29. [PMID: 28271623 DOI: 10.1111/nmo.13037] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 168 |
Lyseng-williamson KA. Bifidobacterium infantis 35624 as a probiotic dietary supplement: a profile of its use. Drugs Ther Perspect 2017;33:368-74. [DOI: 10.1007/s40267-017-0423-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 169 |
Marlicz W, Yung DE, Skonieczna-Żydecka K, Loniewski I, van Hemert S, Loniewska B, Koulaouzidis A. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Rev Gastroenterol Hepatol 2017;11:961-78. [PMID: 28618973 DOI: 10.1080/17474124.2017.1343664] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 170 |
Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr 2017;117:93-107. [PMID: 28102115 DOI: 10.1017/S0007114516004037] [Cited by in Crossref: 240] [Cited by in F6Publishing: 244] [Article Influence: 40.0] [Reference Citation Analysis]
|
| 171 |
Sebastián Domingo JJ. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterología y Hepatología (English Edition) 2017;40:417-429. [DOI: 10.1016/j.gastre.2016.12.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 172 |
Jadrešin O, Hojsak I, Mišak Z, Kekez AJ, Trbojević T, Ivković L, Kolaček S. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study. J Pediatr Gastroenterol Nutr 2017;64:925-9. [PMID: 27906800 DOI: 10.1097/MPG.0000000000001478] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 173 |
Allen AP, Clarke G, Cryan JF, Quigley EMM, Dinan TG. Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms. Current Medical Research and Opinion 2017;33:1349-51. [DOI: 10.1080/03007995.2017.1322571] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 174 |
Rodríguez-Fandiño OA, Hernández-Ruiz J, López-Vidal Y, Charúa-Guindic L, Escobedo G, Schmulson MJ. Maturation Phenotype of Peripheral Blood Monocyte/Macrophage After Stimulation with Lipopolysaccharides in Irritable Bowel Syndrome. J Neurogastroenterol Motil 2017;23:281-8. [PMID: 28044051 DOI: 10.5056/jnm16137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 175 |
Nobutani K, Sawada D, Fujiwara S, Kuwano Y, Nishida K, Nakayama J, Kutsumi H, Azuma T, Rokutan K. The effects of administration of the Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome. J Appl Microbiol 2017;122:212-24. [PMID: 27761980 DOI: 10.1111/jam.13329] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 176 |
Valdovinos M, Montijo E, Abreu A, Heller S, González-garay A, Bacarreza D, Bielsa-fernández M, Bojórquez-ramos M, Bosques-padilla F, Burguete-garcía A, Carmona-sánchez R, Consuelo-sánchez A, Coss-adame E, Chávez-barrera J, de Ariño M, Flores-calderón J, Gómez-escudero O, González-huezo M, Icaza-chávez M, Larrosa-haro A, Morales-arámbula M, Murata C, Ramírez-mayans J, Remes-troche J, Rizo-robles T, Peláez-luna M, Toro-monjaraz E, Torre A, Urquidi-rivera M, Vázquez R, Yamamoto-furusho J, Guarner F. The Mexican consensus on probiotics in gastroenterology. Revista de Gastroenterología de México (English Edition) 2017;82:156-178. [DOI: 10.1016/j.rgmxen.2017.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 177 |
Hustoft TN, Hausken T, Ystad SO, Valeur J, Brokstad K, Hatlebakk JG, Lied GA. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil 2017;29. [PMID: 27747984 DOI: 10.1111/nmo.12969] [Cited by in Crossref: 117] [Cited by in F6Publishing: 92] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 178 |
Celiberto LS, Bedani R, Rossi EA, Cavallini DC. Probiotics: The scientific evidence in the context of inflammatory bowel disease. Crit Rev Food Sci Nutr 2017;57:1759-68. [PMID: 25996176 DOI: 10.1080/10408398.2014.941457] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 179 |
Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Curr Med Res Opin. 2017;33:1191-1197. [PMID: 28166427 DOI: 10.1080/03007995.2017.1292230] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 180 |
Sebastián Domingo JJ. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterol Hepatol 2017;40:417-29. [PMID: 28185664 DOI: 10.1016/j.gastrohep.2016.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 181 |
Valdovinos MA, Montijo E, Abreu AT, Heller S, González-Garay A, Bacarreza D, Bielsa-Fernández M, Bojórquez-Ramos MC, Bosques-Padilla F, Burguete-García AI, Carmona-Sánchez R, Consuelo-Sánchez A, Coss-Adame E, Chávez-Barrera JA, de Ariño M, Flores-Calderón J, Gómez-Escudero O, González-Huezo MS, Icaza-Chávez ME, Larrosa-Haro A, Morales-Arámbula M, Murata C, Ramírez-Mayans JA, Remes-Troche JM, Rizo-Robles T, Peláez-Luna M, Toro-Monjaraz EM, Torre A, Urquidi-Rivera ME, Vázquez R, Yamamoto-Furusho JK, Guarner F. The Mexican consensus on probiotics in gastroenterology. Rev Gastroenterol Mex 2017;82:156-78. [PMID: 28104319 DOI: 10.1016/j.rgmx.2016.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 182 |
Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World J Gastroenterol 2017; 23(2): 336-344 [PMID: 28127207 DOI: 10.3748/wjg.v23.i2.336] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 183 |
Freitas M. The Benefits of Yogurt, Cultures, and Fermentation. The Microbiota in Gastrointestinal Pathophysiology 2017. [DOI: 10.1016/b978-0-12-804024-9.00024-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 184 |
El-chammas KI, Sood MR. Irritable Bowel Syndrome and Functional GI Disorders in Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_52] [Reference Citation Analysis]
|
| 185 |
Preidis GA, Chumpitazi BP, Shulman RJ. The Microbiome in Neurogastroenterology. Pediatric Neurogastroenterology 2017. [DOI: 10.1007/978-3-319-43268-7_5] [Reference Citation Analysis]
|
| 186 |
Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. J Clin Gastroenterol 2017;51:e5-e10. [PMID: 27306945 DOI: 10.1097/MCG.0000000000000528] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 187 |
Glibowski P, Skrzypczak K. Prebiotic and Synbiotic Foods. Microbial Production of Food Ingredients and Additives 2017. [DOI: 10.1016/b978-0-12-811520-6.00006-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 188 |
Navarro F, Liu Y, Rhoads JM. Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol 2016; 22(46): 10093-10102 [PMID: 28028357 DOI: 10.3748/wjg.v22.i46.10093] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 91] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 189 |
Madisch A. Diagnose und Therapie des Reizdarmsyndroms. CME 2016;13:9-17. [DOI: 10.1007/s11298-016-5750-y] [Reference Citation Analysis]
|
| 190 |
Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil. 2016;22:558-574. [PMID: 27431236 DOI: 10.5056/jnm16001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 14.9] [Reference Citation Analysis]
|
| 191 |
Currò D, Ianiro G, Pecere S, Bibbò S, Cammarota G. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol 2017;174:1426-49. [PMID: 27696378 DOI: 10.1111/bph.13632] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 192 |
Sánchez B, Delgado S, Blanco-Míguez A, Lourenço A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res 2017;61. [PMID: 27500859 DOI: 10.1002/mnfr.201600240] [Cited by in Crossref: 463] [Cited by in F6Publishing: 492] [Article Influence: 66.1] [Reference Citation Analysis]
|
| 193 |
Eales J, Gibson P, Whorwell P, Kellow J, Yellowlees A, Perry RH, Edwards M, King S, Wood H, Glanville J. Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol 2017;10:74-88. [PMID: 28286561 DOI: 10.1177/1756283X16670075] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 194 |
Quigley EM, Fried M, Gwee KA, Khalif I, Hungin AP, Lindberg G, Abbas Z, Fernandez LB, Bhatia SJ, Schmulson M, Olano C, LeMair A; Review Team:. World Gastroenterology Organisation Global Guidelines Irritable Bowel Syndrome: A Global Perspective Update September 2015. J Clin Gastroenterol 2016;50:704-13. [PMID: 27623513 DOI: 10.1097/MCG.0000000000000653] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 195 |
Carlson J, Slavin J. Health benefits of fibre, prebiotics and probiotics: a review of intestinal health and related health claims. Quality Assurance and Safety of Crops & Foods 2016;8:539-54. [DOI: 10.3920/qas2015.0791] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 196 |
Scarpignato C, Bertelé A, Tursi A. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease: Rationale and Current Evidence. J Clin Gastroenterol 2016;50 Suppl 1:S70-3. [PMID: 27622371 DOI: 10.1097/MCG.0000000000000641] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 197 |
Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol 2016; 22(32): 7186-7202 [PMID: 27621567 DOI: 10.3748/wjg.v22.i32.7186] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 62] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 198 |
Grimm V, Riedel CU. Manipulation of the Microbiota Using Probiotics. Adv Exp Med Biol 2016;902:109-17. [PMID: 27161354 DOI: 10.1007/978-3-319-31248-4_8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 199 |
Mezzasalma V, Manfrini E, Ferri E, Sandionigi A, La Ferla B, Schiano I, Michelotti A, Nobile V, Labra M, Di Gennaro P. A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation. Biomed Res Int 2016;2016:4740907. [PMID: 27595104 DOI: 10.1155/2016/4740907] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 200 |
Butel M, Waligora-dupriet A. Probiotics and prebiotics. The Human Microbiota and Chronic Disease 2016. [DOI: 10.1002/9781118982907.ch30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 201 |
Videlock EJ, Chang L. Irritable Bowel Syndrome. Practical Gastroenterology and Hepatology Board Review Toolkit 2016. [DOI: 10.1002/9781119127437.ch65] [Reference Citation Analysis]
|
| 202 |
Moraes-Filho JP, Quigley EM. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review. Arq Gastroenterol 2015;52:331-8. [PMID: 26840477 DOI: 10.1590/S0004-28032015000400015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 203 |
Sweileh WM, Shraim NY, Al-Jabi SW, Sawalha AF, Rahhal B, Khayyat RA, Zyoud SH. Assessing worldwide research activity on probiotics in pediatrics using Scopus database: 1994-2014. World Allergy Organ J 2016;9:25. [PMID: 27504147 DOI: 10.1186/s40413-016-0116-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 204 |
Deng ZH, Chang J. Progress in treatment of irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2016; 24(19): 3009-3017 [DOI: 10.11569/wcjd.v24.i19.3009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 205 |
Weizman Z, Abu-abed J, Binsztok M. Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Pediatrics 2016;174:160-164.e1. [DOI: 10.1016/j.jpeds.2016.04.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 206 |
Zhang Y, Li L, Guo C, Mu D, Feng B, Zuo X, Li Y. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016;16:62. [PMID: 27296254 DOI: 10.1186/s12876-016-0470-z] [Cited by in Crossref: 104] [Cited by in F6Publishing: 111] [Article Influence: 14.9] [Reference Citation Analysis]
|
| 207 |
McKenzie YA, Bowyer RK, Leach H, Gulia P, Horobin J, O'Sullivan NA, Pettitt C, Reeves LB, Seamark L, Williams M, Thompson J, Lomer MC; (IBS Dietetic Guideline Review Group on behalf of Gastroenterology Specialist Group of the British Dietetic Association). British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016;29:549-75. [PMID: 27272325 DOI: 10.1111/jhn.12385] [Cited by in Crossref: 168] [Cited by in F6Publishing: 180] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 208 |
Mckenzie YA, Thompson J, Gulia P, Lomer MCE; (IBS Dietetic Guideline Review Group on behalf of Gastroenterology Specialist Group of the British Dietetic Association). British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016;29:576-92. [DOI: 10.1111/jhn.12386] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 209 |
Šmid A, Strniša L, Bajc K, Vujić-podlipec D, Bogovič Matijašić B, Rogelj I. Randomized clinical trial: The effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacterium BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adults. Journal of Functional Foods 2016;24:549-57. [DOI: 10.1016/j.jff.2016.04.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 210 |
Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, Ota M, Koga N, Hattori K, Kunugi H. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord. 2016;202:254-257. [PMID: 27288567 DOI: 10.1016/j.jad.2016.05.038] [Cited by in Crossref: 302] [Cited by in F6Publishing: 240] [Article Influence: 43.1] [Reference Citation Analysis]
|
| 211 |
Serra J. [Intestinal microbiota]. Aten Primaria 2016;48:345-6. [PMID: 27174738 DOI: 10.1016/j.aprim.2016.04.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 212 |
Han K, Wang J, Seo J, Kim H. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial. J Gastroenterol 2017;52:432-43. [DOI: 10.1007/s00535-016-1224-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 213 |
Khoder G, Al-Menhali AA, Al-Yassir F, Karam SM. Potential role of probiotics in the management of gastric ulcer. Exp Ther Med 2016;12:3-17. [PMID: 27347010 DOI: 10.3892/etm.2016.3293] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 214 |
Harper KN, Sheets GM, Armelagos GJ. Modifying Our Microbial Environment. A Companion to the Anthropology of Environmental Health 2016. [DOI: 10.1002/9781118786949.ch18] [Reference Citation Analysis]
|
| 215 |
McCarville JL, Caminero A, Verdu EF. Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol. 2016;9:580-593. [PMID: 27366225 DOI: 10.1177/1756283X16637819] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 216 |
Hill C, Ross RP, Stanton C, O'toole PW. The Human Microbiome in Health and Disease. Host - Pathogen Interaction 2016. [DOI: 10.1002/9783527682386.ch4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 217 |
Nazemian V, Shadnoush M, Manaheji H, Zaringhalam J. Probiotics and Inflammatory Pain: A Literature Review Study. Middle East J Rehabil Health 2016;3. [DOI: 10.17795/mejrh-36087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 218 |
Majeed M, Nagabhushanam K, Natarajan S, Sivakumar A, Ali F, Pande A, Majeed S, Karri SK. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study. Nutr J 2016;15:21. [PMID: 26922379 DOI: 10.1186/s12937-016-0140-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 219 |
Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol 2016; 22(7): 2219-2241 [PMID: 26900286 DOI: 10.3748/wjg.v22.i7.2219] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 208] [Article Influence: 28.9] [Reference Citation Analysis]
|
| 220 |
Morales ME, Ruiz MA. Microencapsulation of probiotic cells: applications in nutraceutic and food industry. Nutraceuticals 2016. [DOI: 10.1016/b978-0-12-804305-9.00016-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 221 |
Thijssen AY, Clemens CH, Vankerckhoven V, Goossens H, Jonkers DM, Masclee AA. Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2016;28:8-14. [PMID: 26469356 DOI: 10.1097/MEG.0000000000000484] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 222 |
Abdollahi M, Abdolghaffari AH, Gooshe M, Ghasemi-niri F. Safety of Probiotic Bacteria. Probiotics, Prebiotics, and Synbiotics 2016. [DOI: 10.1016/b978-0-12-802189-7.00015-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 223 |
Lahner E, Annibale B. Symbiotics, Probiotics, and Fiber Diet in Diverticular Disease. Probiotics, Prebiotics, and Synbiotics 2016. [DOI: 10.1016/b978-0-12-802189-7.00035-6] [Reference Citation Analysis]
|
| 224 |
Zuppa AA, Alighieri G, Scorrano A, Catenazzi P. Prebiotics and Probiotics in Infant Nutrition. Probiotics, Prebiotics, and Synbiotics 2016. [DOI: 10.1016/b978-0-12-802189-7.00008-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 225 |
O’ Mahony SM, Stilling RM, Dinan TG, Cryan JF. The microbiome and childhood diseases: Focus on brain-gut axis: MICROBIOME AND CHILDHOOD DISEASES. Birth Defect Res C 2015;105:296-313. [DOI: 10.1002/bdrc.21118] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 226 |
Tominaga K, Fujikawa Y, Tanaka F, Tanigawa T, Watanabe T, Fujiwara Y, Arakawa T. Pharmacological Treatment for Functional Dyspepsia and Irritable Bowel Syndrome : Current Standards and Promising Therapies. Journal of General and Family Medicine 2015;16:242-51. [DOI: 10.14442/jgfm.16.4_242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 227 |
Tazzyman S, Richards N, Trueman AR, Evans AL, Grant VA, Garaiova I, Plummer SF, Williams EA, Corfe BM. Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: Outcomes from a pilot trial. BMJ Open Gastroenterol. 2015;2:e000052. [PMID: 26719813 DOI: 10.1136/bmjgast-2015-000052] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 228 |
Cash BD, Lacy BE, Rao T, Earnest DL. Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron? Expert Opin Pharmacother 2016;17:311-22. [PMID: 26559529 DOI: 10.1517/14656566.2016.1118052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 229 |
Videlock EJ, Chang L. Irritable Bowel Syndrome. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch75] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 230 |
Hecht GA, Gaspar J, Malespin M. Approach to the Patient with Diarrhea. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch41] [Reference Citation Analysis]
|
| 231 |
Joshi MR. Examining the role of probiotics in the hospital setting. Gastrointestinal Nursing 2015;13:42-49. [DOI: 10.12968/gasn.2015.13.9.42] [Reference Citation Analysis]
|
| 232 |
Quigley EM. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence. J Clin Gastroenterol 2015;49 Suppl 1:S60-4. [PMID: 26447967 DOI: 10.1097/MCG.0000000000000348] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 233 |
Martinez RC, Bedani R, Saad SM. Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. Br J Nutr. 2015;114:1993-2015. [PMID: 26443321 DOI: 10.1017/s0007114515003864] [Cited by in Crossref: 110] [Cited by in F6Publishing: 112] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 234 |
Mazurak N, Broelz E, Storr M, Enck P. Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It? J Neurogastroenterol Motil. 2015;21:471-485. [PMID: 26351253 DOI: 10.5056/jnm15071] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 235 |
Liegl G, Plessen CY, Leitner A, Boeckle M, Pieh C. Guided self-help interventions for irritable bowel syndrome: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2015;27:1209-21. [PMID: 26164395 DOI: 10.1097/MEG.0000000000000428] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 236 |
Da Silva S, Robbe-Masselot C, Raymond A, Mercade-Loubière M, Salvador-Cartier C, Ringot B, Léonard R, Fourquaux I, Ait-Belgnaoui A, Loubière P, Théodorou V, Mercier-Bonin M. Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress. PLoS One 2015;10:e0136048. [PMID: 26367538 DOI: 10.1371/journal.pone.0136048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 237 |
Barboza JL, Talley NJ, Moshiree B. Current and emerging pharmacotherapeutic options for irritable bowel syndrome. Drugs 2014;74:1849-70. [PMID: 25260888 DOI: 10.1007/s40265-014-0292-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 238 |
Spiller R, Pélerin F, Cayzeele Decherf A, Maudet C, Housez B, Cazaubiel M, Jüsten P. Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterol J. 2016;4:353-362. [PMID: 27403301 DOI: 10.1177/2050640615602571] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 239 |
Morgan AR, Han DY, Wickens K, Barthow C, Mitchell EA, Stanley TV, Dekker J, Crane J, Ferguson LR. Differential modification of genetic susceptibility to childhood eczema by two probiotics. Clin Exp Allergy 2014;44:1255-65. [PMID: 25146491 DOI: 10.1111/cea.12394] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 240 |
Mizock BA. Probiotics. Disease-a-Month 2015;61:259-90. [DOI: 10.1016/j.disamonth.2015.03.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 241 |
Vicari E, La Vignera S, Castiglione R, Condorelli RA, Vicari LO, Calogero AE. Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3. Asian J Androl. 2014;16:735-739. [PMID: 24969056 DOI: 10.4103/1008-682x.131064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 242 |
Gao J, Gillilland MG 3rd, Owyang C. Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship. Gut Microbes 2014;5:571-5. [PMID: 25244596 DOI: 10.4161/gmic.32130] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 243 |
Quigley EMM. Probiotics in Gastrointestinal Disorders. Hospital Practice 2015;38:122-9. [DOI: 10.3810/hp.2010.11.349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 244 |
Burokas A, Moloney RD, Dinan TG, Cryan JF. Microbiota regulation of the Mammalian gut-brain axis. Adv Appl Microbiol 2015;91:1-62. [PMID: 25911232 DOI: 10.1016/bs.aambs.2015.02.001] [Cited by in Crossref: 157] [Cited by in F6Publishing: 169] [Article Influence: 19.6] [Reference Citation Analysis]
|
| 245 |
Deiana S, Gabbani T, Bagnoli S, Annese V. Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opin Emerg Drugs 2015;20:247-61. [PMID: 25732091 DOI: 10.1517/14728214.2015.1013935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 246 |
Hajela N, Ramakrishna BS, Nair GB, Abraham P, Gopalan S, Ganguly NK. Gut microbiome, gut function, and probiotics: Implications for health. Indian J Gastroenterol 2015;34:93-107. [PMID: 25917520 DOI: 10.1007/s12664-015-0547-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 247 |
Glickman-simon R, Wallace J. Acupuncture for Knee Osteoarthritis, Chasteberry for Premenstrual Syndrome, Probiotics for Irritable Bowel Syndrome, Yoga for Hypertension, and Trigger Point Dry Needling for Plantar Fasciitis. EXPLORE 2015;11:157-61. [DOI: 10.1016/j.explore.2014.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 248 |
Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 2014;34:15490-6. [PMID: 25392516 DOI: 10.1523/JNEUROSCI.3299-14.2014] [Cited by in Crossref: 534] [Cited by in F6Publishing: 556] [Article Influence: 66.8] [Reference Citation Analysis]
|
| 249 |
Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci. 2014;34:15490-15496. [PMID: 25392516 DOI: 10.1523/jneurosci.3299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 250 |
Pineton de Chambrun G, Neut C, Chau A, Cazaubiel M, Pelerin F, Justen P, Desreumaux P. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome. Dig Liver Dis 2015;47:119-24. [PMID: 25488056 DOI: 10.1016/j.dld.2014.11.007] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 251 |
Coffin B. Quoi de neuf sur les troubles fonctionnels intestinaux depuis la fin du dernier millénaire ? Colon Rectum 2015;9:8-12. [DOI: 10.1007/s11725-015-0560-4] [Reference Citation Analysis]
|
| 252 |
Gomi A, Iino T, Nonaka C, Miyazaki K, Ishikawa F. Health benefits of fermented milk containing Bifidobacterium bifidum YIT 10347 on gastric symptoms in adults. J Dairy Sci 2015;98:2277-83. [PMID: 25648808 DOI: 10.3168/jds.2014-9158] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 253 |
Ringstrom G, Sjovall H, Simrén M, Ung EJ. The importance of a person-centered approach in diagnostic workups of patients with irritable bowel syndrome: a qualitative study. Gastroenterol Nurs 2013;36:443-51. [PMID: 24304529 DOI: 10.1097/SGA.0000000000000011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 254 |
Fukudo S, Hahm KB, Zhu Q, Sollano JD, Rani AA, Syam AF, Kachintorn U, Suzuki H, Kamiya T, Joh T, Uchiyama K, Naito Y, Takahashi S, Kinoshita Y, Ueno F, Yamagami H, Chan FK, Fock KM, Arakawa T; International Gastrointestinal Consensus Symposium Study Group. Survey of clinical practice for irritable bowel syndrome in East asian countries. Digestion 2015;91:99-109. [PMID: 25632923 DOI: 10.1159/000369078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 255 |
Ahmad OF, Akbar A. Dietary treatment of irritable bowel syndrome. Br Med Bull 2015;113:83-90. [PMID: 25601299 DOI: 10.1093/bmb/ldu039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 256 |
Lunder M. Reviewing clinical studies of probiotics as dietary supplements: probiotics for gastrointestinal disorders, Helicobacter eradication, lactose malabsorption and inflammatory bowel disease (IBD). Dietary Supplements 2015. [DOI: 10.1533/9781782420811.3.171] [Reference Citation Analysis]
|
| 257 |
Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49. [PMID: 25446728 DOI: 10.1038/nrgastro.2014.200] [Cited by in Crossref: 128] [Cited by in F6Publishing: 105] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 258 |
Fareez IM, Lim SM, Mishra RK, Ramasamy K. Chitosan coated alginate–xanthan gum bead enhanced pH and thermotolerance of Lactobacillus plantarum LAB12. International Journal of Biological Macromolecules 2015;72:1419-28. [DOI: 10.1016/j.ijbiomac.2014.10.054] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 259 |
Patwardhan B, Mutalik G, Tillu G. Health Supplements. Integrative Approaches for Health 2015. [DOI: 10.1016/b978-0-12-801282-6.00008-5] [Reference Citation Analysis]
|
| 260 |
Tlaskalova-hogenova H, Kverka M, Verdu EF, Wells JM. Gnotobiology and the Study of Complex Interactions between the Intestinal Microbiota, Probiotics, and the Host. Mucosal Immunology 2015. [DOI: 10.1016/b978-0-12-415847-4.00008-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 261 |
Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015;50:11-30. [PMID: 25500976 DOI: 10.1007/s00535-014-1017-0] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 262 |
Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, Simonsen MH, Burisch J, Munkholm P. Ehealth: Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014; 20(43): 16215-16226 [PMID: 25473176 DOI: 10.3748/wjg.v20.i43.16215] [Cited by in CrossRef: 117] [Cited by in F6Publishing: 115] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 263 |
Borre YE, Moloney RD, Clarke G, Dinan TG, Cryan JF. The impact of microbiota on brain and behavior: mechanisms & amp; therapeutic potential. Adv Exp Med Biol. 2014;817:373-403. [PMID: 24997043 DOI: 10.1007/978-1-4939-0897-4_17] [Cited by in Crossref: 195] [Cited by in F6Publishing: 151] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 264 |
Quigley EM, Shanahan F. The future of probiotics for disorders of the brain-gut axis. Adv Exp Med Biol 2014;817:417-32. [PMID: 24997045 DOI: 10.1007/978-1-4939-0897-4_19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 265 |
Jing F, Zhang J. Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders. Dig Dis Sci 2014;59:2642-8. [PMID: 24916714 DOI: 10.1007/s10620-014-3244-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 266 |
Shivaji UN, Ford AC. Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality. Prim Health Care Res Dev 2015;16:263-9. [DOI: 10.1017/s1463423614000383] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 267 |
Deary V, Metcalfe L, Wilson JA. Persistent (unexplained) physical symptoms: evidence-based highlights. British Journal of Hospital Medicine 2014;75:564-7. [DOI: 10.12968/hmed.2014.75.10.564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 268 |
Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1547-61; quiz 1546, 1562. [PMID: 25070051 DOI: 10.1038/ajg.2014.202] [Cited by in Crossref: 487] [Cited by in F6Publishing: 485] [Article Influence: 54.1] [Reference Citation Analysis]
|
| 269 |
Liu ZH, Kang L, Wang JP. Basic and clinical research on the regulation of the intestinal barrier by Lactobacillus and its active protein components: a review with experience of one center. Mol Biol Rep 2014;41:8037-46. [PMID: 25185994 DOI: 10.1007/s11033-014-3701-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 270 |
Ross SM. Psychobiotics: An Emerging Treatment in Stress-Related Disorders. Holistic Nursing Practice 2014;28:329-33. [DOI: 10.1097/hnp.0000000000000047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 271 |
Moran C, Shanahan F. Editorial: probiotics and IBS - where are we now? Aliment Pharmacol Ther 2014;40:318. [PMID: 25040745 DOI: 10.1111/apt.12836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 272 |
Mullin GE, Shepherd SJ, Chander Roland B, Ireton-Jones C, Matarese LE. Irritable bowel syndrome: contemporary nutrition management strategies. JPEN J Parenter Enteral Nutr. 2014;38:781-799. [PMID: 25085503 DOI: 10.1177/0148607114545329] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 273 |
Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 2014;11:497-505. [PMID: 24751910 DOI: 10.1038/nrgastro.2014.40] [Cited by in Crossref: 229] [Cited by in F6Publishing: 220] [Article Influence: 25.4] [Reference Citation Analysis]
|
| 274 |
Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Quigley EM; Task Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014;109 Suppl 1:S2-26; quiz S27. [PMID: 25091148 DOI: 10.1038/ajg.2014.187] [Cited by in Crossref: 403] [Cited by in F6Publishing: 416] [Article Influence: 44.8] [Reference Citation Analysis]
|
| 275 |
Magro DO, de Oliveira LM, Bernasconi I, Ruela Mde S, Credidio L, Barcelos IK, Leal RF, Ayrizono Mde L, Fagundes JJ, Teixeira Lde B. Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation. Nutr J. 2014;13:75. [PMID: 25056655 DOI: 10.1186/1475-2891-13-75] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 276 |
Wall GC, Bryant GA, Bottenberg MM, Maki ED, Miesner AR. Irritable bowel syndrome: A concise review of current treatment concepts. World J Gastroenterol 2014; 20(27): 8796-8806 [PMID: 25083054 DOI: 10.3748/wjg.v20.i27.8796] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 277 |
Wall GC, Bryant GA, Bottenberg MM, Maki ED, Miesner AR. Irritable bowel syndrome: A concise review of current treatment concepts. WJG 2014;20:8796-806. [DOI: 10.3748/wjg.v20.i27.5796] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 278 |
Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol 2014; 20(27): 8886-8897 [PMID: 25083061 DOI: 10.3748/wjg.v20.i27.8886] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
|
| 279 |
Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: A disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol 2014; 20(27): 8807-8820 [PMID: 25083055 DOI: 10.3748/wjg.v20.i27.8807] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
|
| 280 |
Lorenzo-Zúñiga V, Llop E, Suárez C, Álvarez B, Abreu L, Espadaler J, Serra J. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol 2014; 20(26): 8709-8716 [PMID: 25024629 DOI: 10.3748/wjg.v20.i26.8709] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 81] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 281 |
Zatorski H, Fichna J. What is the Future of the Gut Microbiota-Related Treatment? Toward Modulation of Microbiota in Preventive and Therapeutic Medicine. Front Med (Lausanne). 2014;1:19. [PMID: 25705630 DOI: 10.3389/fmed.2014.00019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 282 |
Del Chierico F, Vernocchi P, Dallapiccola B, Putignani L. Mediterranean diet and health: food effects on gut microbiota and disease control. Int J Mol Sci. 2014;15:11678-11699. [PMID: 24987952 DOI: 10.3390/ijms150711678] [Cited by in Crossref: 120] [Cited by in F6Publishing: 124] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 283 |
Shavakhi A, Minakari M, Farzamnia S, Peykar MS, Taghipour G, Tayebi A, Hashemi H, Shavakhi S. The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial. Adv Biomed Res. 2014;3:140. [PMID: 25161987 DOI: 10.4103/2277-9175.135157] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 284 |
Eswaran S, Guentner A, Chey WD. Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation. J Neurogastroenterol Motil. 2014;20:141-151. [PMID: 24840367 DOI: 10.5056/jnm.2014.20.2.141] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 285 |
De Palma G, Collins SM, Bercik P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes. 2014;5:419-429. [PMID: 24921926 DOI: 10.4161/gmic.29417] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 286 |
Doré J, Simrén M, Buttle L, Guarner F. Hot topics in gut microbiota. United European Gastroenterol J. 2013;1:311-318. [PMID: 24917977 DOI: 10.1177/2050640613502477] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 287 |
Magge SS, Wolf JL. Complementary and alternative medicine and mind-body therapies for treatment of irritable bowel syndrome in women. Womens Health (Lond) 2013;9:557-67. [PMID: 24161308 DOI: 10.2217/whe.13.57] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 288 |
de Greck M, Layer P, Andresen V. Schmerztherapie beim Reizdarmsyndrom. Schmerz 2014;28:289-93. [DOI: 10.1007/s00482-014-1406-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 289 |
Gibson MK, Pesesky MW, Dantas G. The yin and yang of bacterial resilience in the human gut microbiota. J Mol Biol 2014;426:3866-76. [PMID: 24911583 DOI: 10.1016/j.jmb.2014.05.029] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 290 |
Butel M. Les probiotiques et leur place en médecine humaine. Journal des Anti-infectieux 2014;16:33-43. [DOI: 10.1016/j.antinf.2014.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 291 |
Chang YM, El-Zaatari M, Kao JY. Does stress induce bowel dysfunction? Expert Rev Gastroenterol Hepatol 2014;8:583-5. [PMID: 24881644 DOI: 10.1586/17474124.2014.911659] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 292 |
Vanuytsel T, Tack JF, Boeckxstaens GE. Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol. 2014;49:1193-1205. [PMID: 24845149 DOI: 10.1007/s00535-014-0966-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 293 |
Sanders ME, Lenoir-Wijnkoop I, Salminen S, Merenstein DJ, Gibson GR, Petschow BW, Nieuwdorp M, Tancredi DJ, Cifelli CJ, Jacques P. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci. 2014;1309:19-29. [PMID: 24571254 DOI: 10.1111/nyas.12377] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 294 |
Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology 2014;146:1554-63. [PMID: 24486051 DOI: 10.1053/j.gastro.2014.01.050] [Cited by in Crossref: 125] [Cited by in F6Publishing: 128] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 295 |
Ludidi S, Jonkers DM, Koning CJ, Kruimel JW, Mulder L, van der Vaart IB, Conchillo JM, Masclee AA. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients. Neurogastroenterol Motil 2014;26:705-14. [PMID: 24588932 DOI: 10.1111/nmo.12320] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 296 |
Dupont HL. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther 2014;39:1033-42. [PMID: 24665829 DOI: 10.1111/apt.12728] [Cited by in Crossref: 113] [Cited by in F6Publishing: 109] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 297 |
Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 2014;146:1500-12. [PMID: 24583088 DOI: 10.1053/j.gastro.2014.02.037] [Cited by in Crossref: 283] [Cited by in F6Publishing: 295] [Article Influence: 31.4] [Reference Citation Analysis]
|
| 298 |
Marques TM, Cryan JF, Shanahan F, Fitzgerald GF, Ross RP, Dinan TG, Stanton C. Gut microbiota modulation and implications for host health: Dietary strategies to influence the gut–brain axis. Innovative Food Science & Emerging Technologies 2014;22:239-47. [DOI: 10.1016/j.ifset.2013.10.016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 299 |
Korterink JJ, Ockeloen L, Benninga MA, Tabbers MM, Hilbink M, Deckers-Kocken JM. Probiotics for childhood functional gastrointestinal disorders: a systematic review and meta-analysis. Acta Paediatr 2014;103:365-72. [PMID: 24236577 DOI: 10.1111/apa.12513] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 300 |
Oliver L, Rasmussen H, Gregoire MB, Chen Y. Health Care Provider's Knowledge, Perceptions, and Use of Probiotics and Prebiotics. Topics in Clinical Nutrition 2014;29:139-49. [DOI: 10.1097/01.tin.0000445898.98017.eb] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 301 |
Lee YY. What's New in the Toolbox for Constipation and Fecal Incontinence? Front Med (Lausanne) 2014;1:5. [PMID: 25705618 DOI: 10.3389/fmed.2014.00005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 302 |
Pasanen ME. Evaluation and treatment of colonic symptoms. Med Clin North Am 2014;98:529-47. [PMID: 24758959 DOI: 10.1016/j.mcna.2014.01.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 303 |
Bye W, Ishaq N, Bolin TD, Duncombe VM, Riordan SM. Overgrowth of the indigenous gut microbiome and irritable bowel syndrome. World J Gastroenterol 2014; 20(10): 2449-2455 [PMID: 24627582 DOI: 10.3748/wjg.v20.i10.2449] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 304 |
Chang FY. Irritable bowel syndrome: The evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol 2014; 20(10): 2499-2514 [PMID: 24627587 DOI: 10.3748/wjg.v20.i10.2499] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 305 |
Hong SN, Rhee PL. Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol 2014; 20(10): 2470-2481 [PMID: 24627584 DOI: 10.3748/wjg.v20.i10.2470] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 306 |
Wang H, Gong J, Wang W, Long Y, Fu X, Fu Y, Qian W, Hou X. Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model? PLoS One. 2014;9:e90153. [PMID: 24595218 DOI: 10.1371/journal.pone.0090153] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 307 |
Tomaro-duchesneau C, Saha S, Prakash S. Modification of the gut microbiota to promote human health. Clinical Insights: Probiotics, Prebiotics and Gut Health 2014. [DOI: 10.2217/ebo.13.501] [Reference Citation Analysis]
|
| 308 |
Quigley EM. Use of probiotics in irritable bowel syndrome. Clinical Insights: Probiotics, Prebiotics and Gut Health 2014. [DOI: 10.2217/ebo.13.517] [Reference Citation Analysis]
|
| 309 |
Cada DJ, Levien TL, Baker DE. Linaclotide. Hosp Pharm 2013;48:143-52. [PMID: 24421452 DOI: 10.1310/hpj4802-143.test] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 310 |
Cada DJ, Levien TL, Baker DE. Linaclotide. Hosp Pharm 2013;48:143-52. [PMID: 24421452 DOI: 10.1310/hpj4802-143.test] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 311 |
Vindigni SM, Broussard EK, Surawicz CM. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Review of Gastroenterology & Hepatology 2014;7:615-28. [DOI: 10.1586/17474124.2013.832501] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 312 |
Layer P. Management of irritable bowel syndrome with constipation: a flexible approach to treating a complex condition with multiple symptoms. Expert Review of Gastroenterology & Hepatology 2014;7:9-14. [DOI: 10.1586/17474124.2013.820049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 313 |
Cremon C, Carini G, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon? Expert Review of Molecular Diagnostics 2014;10:389-93. [DOI: 10.1586/erm.10.33] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 314 |
Lacy BE, Oʼshana T. Clinical Pearls for Irritable Bowel Syndrome: Management of the Diarrhea-Predominant Subtype. Gastroenterology Nursing 2014;37:392-405. [DOI: 10.1097/sga.0000000000000056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 315 |
Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol 2014;29:52-9. [PMID: 23829297 DOI: 10.1111/jgh.12322] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 316 |
Crişan IM, Dumitraşcu DL. Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic Implications. Clujul Med 2014;87:73-9. [PMID: 26528001 DOI: 10.15386/cjmed-269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 317 |
Taft T, Riehl M. Gastrointestinal Conditions. Handbook of Clinical Psychology in Medical Settings 2014. [DOI: 10.1007/978-0-387-09817-3_18] [Reference Citation Analysis]
|
| 318 |
Engsbro AL, Stensvold CR, Vedel Nielsen H, Bytzer P. Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome. Scand J Infect Dis. 2014;46:204-209. [PMID: 24344761 DOI: 10.3109/00365548.2013.861609] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 319 |
Akpınar H. Probiotics for Gastrointestinal Diseases. Probiotics and Prebiotics in Food, Nutrition and Health 2013. [DOI: 10.1201/b15561-16] [Reference Citation Analysis]
|
| 320 |
Butel MJ. Probiotics, gut microbiota and health. Med Mal Infect. 2014;44:1-8. [PMID: 24290962 DOI: 10.1016/j.medmal.2013.10.002] [Cited by in Crossref: 215] [Cited by in F6Publishing: 225] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 321 |
Thompson A, Meah D, Ahmed N, Conniff-Jenkins R, Chileshe E, Phillips CO, Claypole TC, Forman DW, Row PE. Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome. BMC Complement Altern Med 2013;13:338. [PMID: 24283351 DOI: 10.1186/1472-6882-13-338] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 322 |
Moloney RD, Desbonnet L, Clarke G, Dinan TG, Cryan JF. The microbiome: stress, health and disease. Mamm Genome. 2014;25:49-74. [PMID: 24281320 DOI: 10.1007/s00335-013-9488-5] [Cited by in Crossref: 279] [Cited by in F6Publishing: 228] [Article Influence: 27.9] [Reference Citation Analysis]
|
| 323 |
Sood R, Ford AC. Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome. Ther Adv Chronic Dis. 2013;4:268-276. [PMID: 24179669 DOI: 10.1177/2040622313500110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 324 |
Ford AC, Moayyedi P. Dyspepsia. Curr Opin Gastroenterol 2013;29:662-8. [PMID: 24100727 DOI: 10.1097/MOG.0b013e328365d45d] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 325 |
Read N, Rampersad-smith L. Treating IBS in practice: a new aspect of care. Practice Nursing 2013;24:538-42. [DOI: 10.12968/pnur.2013.24.11.538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 326 |
Athanasakos E, Emmanuel A. Management of patients with ‘refractory’ IBS: how to approach the patientMultiple choice questions. Irritable Bowel Syndrome: Diagnosis and Management. Unitec House: Future Medicine Ltd; 2013. pp. 171-93. [DOI: 10.2217/ebo.13.530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 327 |
Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2013;305:G529-41. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 328 |
Hungin AP, Mulligan C, Pot B, Whorwell P, Agréus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Rubin G, Winchester C, de Wit N; European Society for Primary Care Gastroenterology. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide. Aliment Pharmacol Ther 2013;38:864-86. [PMID: 23981066 DOI: 10.1111/apt.12460] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 329 |
Ng SC, Lam EF, Lam TT, Chan Y, Law W, Tse PC, Kamm MA, Sung JJ, Chan FK, Wu JC. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome. J Gastroenterol Hepatol 2013;28:1624-31. [PMID: 23800182 DOI: 10.1111/jgh.12306] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 330 |
Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013;48:1127-35. [PMID: 23957590 DOI: 10.3109/00365521.2013.825314] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 331 |
Camilleri M. Irritable bowel syndrome pharmacotherapy. Irritable Bowel Syndrome: Diagnosis and Management 2013. [DOI: 10.2217/ebo.13.456] [Reference Citation Analysis]
|
| 332 |
Ohman L, Simrén M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep. 2013;15:323. [PMID: 23580243 DOI: 10.1007/s11894-013-0323-7] [Cited by in Crossref: 80] [Cited by in F6Publishing: 90] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 333 |
Bonfrate L, Tack J, Grattagliano I, Cuomo R, Portincasa P. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol 2013;48:995-1009. [PMID: 23964766 DOI: 10.3109/00365521.2013.799220] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 334 |
Durbán A, Abellán JJ, Jiménez-Hernández N, Artacho A, Garrigues V, Ortiz V, Ponce J, Latorre A, Moya A. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome. FEMS Microbiol Ecol. 2013;86:581-589. [PMID: 23889283 DOI: 10.1111/1574-6941.12184] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 335 |
Bucci C, Tremolaterra F, Gallotta S, Fortunato A, Cappello C, Ciacci C, Iovino P. A pilot study on the effect of a symbiotic mixture in irritable bowel syndrome: an open-label, partially controlled, 6-month extension of a previously published trial. Tech Coloproctol. 2014;18:345-353. [PMID: 23922211 DOI: 10.1007/s10151-013-1055-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 336 |
Brindley JH, Robinson N. Functional bowel disorders and the role of mind-body therapies—The ‘Editors Choice’. European Journal of Integrative Medicine 2013;5:293-295. [DOI: 10.1016/j.eujim.2013.05.002] [Reference Citation Analysis]
|
| 337 |
Alokail MS, Sabico S, Al-Saleh Y, Al-Daghri NM, Alkharfy KM, Vanhoutte PM, McTernan PG. Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial. Trials 2013;14:195. [PMID: 23822518 DOI: 10.1186/1745-6215-14-195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 338 |
Alokail MS, Sabico S, Al-Saleh Y, Al-Daghri NM, Alkharfy KM, Vanhoutte PM, McTernan PG. Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial. Trials. 2013;14:195. [PMID: 23822518 DOI: 10.1186/1745-6215-14-195] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 339 |
Collins SM, Bercik P. Gut microbiota: Intestinal bacteria influence brain activity in healthy humans. Nat Rev Gastroenterol Hepatol 2013;10:326-7. [PMID: 23648940 DOI: 10.1038/nrgastro.2013.76] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 340 |
Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, Sherman PM, Mayer EA. An update on the use and investigation of probiotics in health and disease. Gut 2013;62:787-96. [PMID: 23474420 DOI: 10.1136/gutjnl-2012-302504] [Cited by in Crossref: 340] [Cited by in F6Publishing: 335] [Article Influence: 34.0] [Reference Citation Analysis]
|
| 341 |
Sabaté J-. Liens entre alimentation et syndrome de l’intestin irritable. Colon Rectum 2013;7:86-92. [DOI: 10.1007/s11725-013-0457-7] [Reference Citation Analysis]
|
| 342 |
Le Nevé B, Posserud I, Böhn L, Guyonnet D, Rondeau P, Tillisch K, Naliboff B, Mayer EA, Simrén M. A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome. Am J Gastroenterol 2013;108:786-95. [PMID: 23588235 DOI: 10.1038/ajg.2013.75] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 343 |
Camilleri M. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opin Pharmacother. 2013;14:1151-1160. [PMID: 23621801 DOI: 10.1517/14656566.2013.794223] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 344 |
Törnblom H, Simrén M. Sequencing the Treatments. Irritable Bowel Syndrome 2013. [DOI: 10.1002/9781118444689.ch14] [Reference Citation Analysis]
|
| 345 |
Ford AC. Definitions and Classifications of Irritable Bowel Syndrome. In: Emmanuel A, Quigley EM, editors. Irritable Bowel Syndrome. Oxford: Blackwell Publishing Ltd; 2013. pp. 1-21. [DOI: 10.1002/9781118444689.ch1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 346 |
Dapoigny M. Food-related Symptoms of Irritable Bowel Syndrome. Irritable Bowel Syndrome 2013. [DOI: 10.1002/9781118444689.ch8] [Reference Citation Analysis]
|
| 347 |
Tack J. Diagnostic and Therapeutic Horizons for Irritable Bowel Syndrome. Irritable Bowel Syndrome 2013. [DOI: 10.1002/9781118444689.ch15] [Reference Citation Analysis]
|
| 348 |
Fontana L, Bermudez-Brito M, Plaza-Diaz J, Muñoz-Quezada S, Gil A. Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr 2013;109 Suppl 2:S35-50. [PMID: 23360880 DOI: 10.1017/S0007114512004011] [Cited by in Crossref: 166] [Cited by in F6Publishing: 171] [Article Influence: 16.6] [Reference Citation Analysis]
|
| 349 |
Charbonneau D, Gibb RD, Quigley EM. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes 2013;4:201-11. [PMID: 23549409 DOI: 10.4161/gmic.24196] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 350 |
Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol 2013;11:359-65.e1. [PMID: 23246645 DOI: 10.1016/j.cgh.2012.11.033] [Cited by in Crossref: 113] [Cited by in F6Publishing: 107] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 351 |
Marteau P, Guyonnet D, Lafaye de Micheaux P, Gelu S. A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms. Neurogastroenterol Motil 2013;25:331-e252. [PMID: 23480238 DOI: 10.1111/nmo.12078] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 352 |
Wang ZK, Yang YS. Upper gastrointestinal microbiota and digestive diseases. World J Gastroenterol 2013; 19(10): 1541-1550 [PMID: 23539678 DOI: 10.3748/wjg.v19.i10.1541] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 353 |
Caselli M, Cassol F, Calò G, Holton J, Zuliani G, Gasbarrini A. Actual concept of "probiotics": Is it more functional to science or business? World J Gastroenterol 2013; 19(10): 1527-1540 [PMID: 23539674 DOI: 10.3748/wjg.v19.i10.1527] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 354 |
Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F, Gil A. Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLoS One 2013;8:e59370. [PMID: 23555025 DOI: 10.1371/journal.pone.0059370] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 355 |
Roberts LM, McCahon D, Holder R, Wilson S, Hobbs FD. A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome. BMC Gastroenterol. 2013;13:45. [PMID: 23496803 DOI: 10.1186/1471-230x-13-45] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 356 |
Wu RY, Pasyk M, Wang B, Forsythe P, Bienenstock J, Mao YK, Sharma P, Stanisz AM, Kunze WA. Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Neurogastroenterol Motil 2013;25:e205-14. [PMID: 23316914 DOI: 10.1111/nmo.12072] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 357 |
Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013;29:184-9. [PMID: 23286925 DOI: 10.1097/MOG.0b013e32835d7bba] [Cited by in Crossref: 137] [Cited by in F6Publishing: 138] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 358 |
Buzás GM. [Probiotics in gastroenterology -- from a different angle]. Orv Hetil 2013;154:294-304. [PMID: 23419530 DOI: 10.1556/OH.2013.29547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 359 |
Guyonnet D, Naliboff B, Rondeau P, Mayer E, Chassany O. Gastrointestinal well-being in subjects reporting mild gastrointestinal discomfort: characteristics and properties of a global assessment measure. Br J Nutr 2013;110:1263-71. [PMID: 23432848 DOI: 10.1017/S0007114513000275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 360 |
McVey Neufeld KA, Mao YK, Bienenstock J, Foster JA, Kunze WA. The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol Motil 2013;25:183-e88. [PMID: 23181420 DOI: 10.1111/nmo.12049] [Cited by in Crossref: 200] [Cited by in F6Publishing: 197] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 361 |
Duncan B. Prebiotics, Probiotics, and Health Promotion:. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease 2013. [DOI: 10.1016/b978-0-12-397154-8.00005-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 362 |
El-chammas KI, Sood MR. Irritable Bowel Syndrome and Functional Gastrointestinal Disorders in Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_46] [Reference Citation Analysis]
|
| 363 |
Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG; Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-76. [PMID: 22730468 DOI: 10.1136/gutjnl-2012-302167] [Cited by in Crossref: 586] [Cited by in F6Publishing: 531] [Article Influence: 58.6] [Reference Citation Analysis]
|
| 364 |
Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol 2013;10:13-23. [PMID: 23147658 DOI: 10.1038/nrgastro.2012.207] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 365 |
Andoh A, Fujimoto T, Takahashi K. Association between the Gut Microbiota and Intestinal Disorders. J Jpn Soc Intern Med 2013;102:2983-2989. [DOI: 10.2169/naika.102.2983] [Reference Citation Analysis]
|
| 366 |
Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013;25:4-15. [PMID: 23279728 DOI: 10.1111/nmo.12046] [Cited by in Crossref: 163] [Cited by in F6Publishing: 165] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 367 |
Qureshi I, Endres J. Probiotics and Irritable Bowel Syndrome. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease 2013. [DOI: 10.1016/b978-0-12-397154-8.00027-0] [Reference Citation Analysis]
|
| 368 |
Koloski NA, Talley NJ. Irritable Bowel Syndrome. Women and Health 2013. [DOI: 10.1016/b978-0-12-384978-6.00092-3] [Reference Citation Analysis]
|
| 369 |
Voß U, Lewerenz A, Nieber K. Treatment of irritable bowel syndrome: sex and gender specific aspects. Handb Exp Pharmacol 2012;:473-97. [PMID: 23027463 DOI: 10.1007/978-3-642-30726-3_21] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 370 |
Craig OF, Quigley EM. Current and emerging therapies for the management of functional gastrointestinal disorders. Ther Adv Chronic Dis 2011;2:87-99. [PMID: 23251744 DOI: 10.1177/2040622310389507] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 371 |
Almansa C, Agrawal A, Houghton LA. Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2012;6:383-398. [PMID: 22646259 DOI: 10.1586/egh.12.9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 372 |
Quigley EM. Probiotics in the management of functional bowel disorders: promise fulfilled? Gastroenterol Clin North Am 2012;41:805-19. [PMID: 23101688 DOI: 10.1016/j.gtc.2012.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 373 |
O'connor A, Lovei GL, Eales J, Frampton G, Glanville J, Pullin A, Sargeant J. Implementation of systematic reviews in EFSA scientific outputs workflow. EFS3 2012;9. [DOI: 10.2903/sp.efsa.2012.en-367] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 374 |
Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, Versalovic J, Verdu EF, Dinan TG, Hecht G, Guarner F. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes. 2013;4:17-27. [PMID: 23202796 DOI: 10.4161/gmic.22973] [Cited by in Crossref: 145] [Cited by in F6Publishing: 158] [Article Influence: 13.2] [Reference Citation Analysis]
|
| 375 |
Grover S, Rashmi HM, Srivastava AK, Batish VK. Probiotics for human health -new innovations and emerging trends. Gut Pathog 2012;4:15. [PMID: 23181893 DOI: 10.1186/1757-4749-4-15] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 376 |
Lahner E, Esposito G, Zullo A, Hassan C, Cannaviello C, Paolo MCD, Pallotta L, Garbagna N, Grossi E, Annibale B. High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World J Gastroenterol 2012; 18(41): 5918-5924 [PMID: 23139608 DOI: 10.3748/wjg.v18.i41.5918] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 377 |
Nelson AM, Walk ST, Taube S, Taniuchi M, Houpt ER, Wobus CE, Young VB. Disruption of the human gut microbiota following Norovirus infection. PLoS One 2012;7:e48224. [PMID: 23118957 DOI: 10.1371/journal.pone.0048224] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 378 |
Asare F, Störsrud S, Simrén M. Meditation over medication for irritable bowel syndrome? On exercise and alternative treatments for irritable bowel syndrome. Curr Gastroenterol Rep. 2012;14:283-289. [PMID: 22661301 DOI: 10.1007/s11894-012-0268-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 379 |
Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab 2012;61:160-74. [PMID: 23037511 DOI: 10.1159/000342079] [Cited by in Crossref: 606] [Cited by in F6Publishing: 626] [Article Influence: 55.1] [Reference Citation Analysis]
|
| 380 |
Hosseini A, Nikfar S, Abdollahi M. Are probiotics effective in management of irritable bowel syndrome? Arch Med Sci. 2012;8:403-405. [PMID: 22851991 DOI: 10.5114/aoms.2012.29396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 381 |
Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. J Clin Gastroenterol 2012;46 Suppl:S52-5. [PMID: 22955358 DOI: 10.1097/MCG.0b013e318264e918] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 382 |
Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012;107:1474-82. [PMID: 22929759 DOI: 10.1038/ajg.2012.260] [Cited by in Crossref: 388] [Cited by in F6Publishing: 369] [Article Influence: 35.3] [Reference Citation Analysis]
|
| 383 |
Rowland I, Capurso L, Collins K, Cummings J, Delzenne N, Goulet O, Guarner F, Marteau P, Meier R. Current level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009. Gut Microbes 2010;1:436-9. [PMID: 21637035 DOI: 10.4161/gmic.1.6.13610] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 384 |
Ciorba MA. A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol 2012;10:960-8. [PMID: 22504002 DOI: 10.1016/j.cgh.2012.03.024] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 385 |
Glickman-simon R, Basu Ray I. Acupuncture, Lactobacillus Traditional Chinese Herbal Medicine, Sanchitongtshu, and Honey. EXPLORE 2012;8:310-3. [DOI: 10.1016/j.explore.2012.06.009] [Reference Citation Analysis]
|
| 386 |
Hosseini A, Nikfar S, Abdollahi M. Probiotics use to treat irritable bowel syndrome. Expert Opin Biol Ther. 2012;12:1323-1334. [PMID: 22897430 DOI: 10.1517/14712598.2012.707179] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 387 |
Ducrotté P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol 2012; 18(30): 4012-4018 [PMID: 22912552 DOI: 10.3748/wjg.v18.i30.4012] [Cited by in CrossRef: 166] [Cited by in F6Publishing: 170] [Article Influence: 15.1] [Reference Citation Analysis]
|
| 388 |
Cappello C, Tremolaterra F, Pascariello A, Ciacci C, Iovino P. A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life. Int J Colorectal Dis. 2013;28:349-358. [PMID: 22885882 DOI: 10.1007/s00384-012-1552-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 389 |
Farup PG, Jacobsen M, Ligaarden SC, Rudi K. Probiotics, symptoms, and gut microbiota: what are the relations? A randomized controlled trial in subjects with irritable bowel syndrome. Gastroenterol Res Pract 2012;2012:214102. [PMID: 22899904 DOI: 10.1155/2012/214102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 390 |
Ringel Y, Quigley EM, Lin HC. Using Probiotics in Gastrointestinal Disorders. Am J Gastroenterol Suppl 2012;1:34-40. [DOI: 10.1038/ajgsup.2012.7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 391 |
Foxx-orenstein AE, Chey WD. Manipulation of the Gut Microbiota as a Novel Treatment Strategy for Gastrointestinal Disorders. Am J Gastroenterol Suppl 2012;1:41-6. [DOI: 10.1038/ajgsup.2012.8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 392 |
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-721.e4. [PMID: 22426087 DOI: 10.1016/j.cgh.2012.02.029] [Cited by in Crossref: 1222] [Cited by in F6Publishing: 1019] [Article Influence: 111.1] [Reference Citation Analysis]
|
| 393 |
Korpela R, Niittynen L. Probiotics and irritable bowel syndrome. Microb Ecol Health Dis. 2012;23:18573. [PMID: 23990830 DOI: 10.3402/mehd.v23i0.18573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 394 |
Wang WD, Fang XC, Ke MY. Role of food in onset of symptoms and treatment of irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2012; 20(17): 1531-1536 [DOI: 10.11569/wcjd.v20.i17.1531] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 395 |
Dave M, Higgins PD, Middha S, Rioux KP. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res. 2012;160:246-257. [PMID: 22683238 DOI: 10.1016/j.trsl.2012.05.003] [Cited by in Crossref: 180] [Cited by in F6Publishing: 147] [Article Influence: 16.4] [Reference Citation Analysis]
|
| 396 |
Macdonald RS, Wagner K. Influence of dietary phytochemicals and microbiota on colon cancer risk. J Agric Food Chem. 2012;60:6728-6735. [PMID: 22632581 DOI: 10.1021/jf204230r] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 397 |
Bouladoux N, Hall JA, Grainger JR, dos Santos LM, Kann MG, Nagarajan V, Verthelyi D, Belkaid Y. Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunol. 2012;5:623-634. [PMID: 22617839 DOI: 10.1038/mi.2012.36] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 398 |
Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr 2012;54:446-53. [PMID: 22027566 DOI: 10.1097/MPG.0b013e31823d34c3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 399 |
Marteau P. Therapy: Probiotic-enriched artichokes for abdominal discomfort. Nat Rev Gastroenterol Hepatol 2012;9:251-2. [PMID: 22429956 DOI: 10.1038/nrgastro.2012.49] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 400 |
Rodrigues DM, Sousa AJ, Johnson-Henry KC, Sherman PM, Gareau MG. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J Infect Dis. 2012;206:99-109. [PMID: 22430833 DOI: 10.1093/infdis/jis177] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 401 |
Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol 2012;46:220-7. [PMID: 22157240 DOI: 10.1097/MCG.0b013e31823712b1] [Cited by in Crossref: 142] [Cited by in F6Publishing: 143] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 402 |
Durbán A, Abellán JJ, Jiménez-Hernández N, Salgado P, Ponce M, Ponce J, Garrigues V, Latorre A, Moya A. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ Microbiol Rep. 2012;4:242-247. [PMID: 23757279 DOI: 10.1111/j.1758-2229.2012.00327.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 403 |
Mullin GE. Probiotics and Digestive Disease. Nutr Clin Pract 2012;27:300-2. [DOI: 10.1177/0884533612439609] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 404 |
Cash B, Mitchner NA, Ravyn D. Confidence-based learning CME: overcoming barriers in irritable bowel syndrome with constipation. J Contin Educ Health Prof 2011;31:157-64. [PMID: 21953655 DOI: 10.1002/chp.20121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 405 |
Whelan K. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care. 2011;14:581-587. [PMID: 21892075 DOI: 10.1097/mco.0b013e32834b8082] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 406 |
Quigley EM. Commensal bacteria: the link between IBS and IBD? Curr Opin Clin Nutr Metab Care. 2011;14:497-503. [PMID: 21673572 DOI: 10.1097/mco.0b013e328348c033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 407 |
Häuser W, Layer P, Henningsen P, Kruis W. Functional bowel disorders in adults. Dtsch Arztebl Int 2012;109:83-94. [PMID: 22368721 DOI: 10.3238/arztebl.2012.0083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 408 |
Clarke G, Cryan JF, Dinan TG, Quigley EM. Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria. Aliment Pharmacol Ther 2012;35:403-13. [PMID: 22225517 DOI: 10.1111/j.1365-2036.2011.04965.x] [Cited by in Crossref: 148] [Cited by in F6Publishing: 149] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 409 |
O’connor OJ, Mcsweeney SE, Mcwilliams S, O’neill S, Shanahan F, Quigley EMM, Maher MM. Role of Radiologic Imaging in Irritable Bowel Syndrome: Evidence-based Review. Radiology 2012;262:485-94. [DOI: 10.1148/radiol.11110423] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 410 |
O'Sullivan E, Barrett E, Grenham S, Fitzgerald P, Stanton C, Ross RP, Quigley EM, Cryan JF, Dinan TG. BDNF expression in the hippocampus of maternally separated rats: Does Bifidobacterium breve 6330 alter BDNF levels? Benef Microbes. 2011;2:199-207. [PMID: 21986359 DOI: 10.3920/bm2011.0015] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 411 |
Larauche M, Mulak A, Yuan PQ, Kanauchi O, Taché Y. Stress-induced visceral analgesia assessed non-invasively in rats is enhanced by prebiotic diet. World J Gastroenterol 2012; 18(3): 225-236 [PMID: 22294825 DOI: 10.3748/wjg.v18.i3.225] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 412 |
Thomas LV, Ockhuizen T. New insights into the impact of the intestinal microbiota on health and disease: a symposium report. Br J Nutr 2012;107:S1-S13. [DOI: 10.1017/s0007114511006970] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 413 |
Cremonini F, Lembo A. Rifaximin for the treatment of irritable bowel syndrome. Expert Opin Pharmacother. 2012;13:433-440. [PMID: 22251066 DOI: 10.1517/14656566.2012.651458] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 414 |
Madsen K. The International Scientific Conference on Probiotics and Prebiotics. Expert Rev Gastroenterol Hepatol 2011;5:571-3. [PMID: 21910573 DOI: 10.1586/egh.11.61] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 415 |
Hanaway PJ. Irritable Bowel Syndrome. Integrative Medicine 2012. [DOI: 10.1016/b978-1-4377-1793-8.00040-6] [Reference Citation Analysis]
|
| 416 |
Bharucha AE, Brookes SJ. Neurophysiologic Mechanisms of Human Large Intestinal Motility. Physiology of the Gastrointestinal Tract 2012. [DOI: 10.1016/b978-0-12-382026-6.00036-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 417 |
Parkes GC, Rayment NB, Hudspith BN, Petrovska L, Lomer MC, Brostoff J, Whelan K, Sanderson JD. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 2012;24:31-9. [PMID: 22070725 DOI: 10.1111/j.1365-2982.2011.01803.x] [Cited by in Crossref: 148] [Cited by in F6Publishing: 147] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 418 |
Adam Rindfleisch J. Prescribing Probiotics. Integrative Medicine 2012. [DOI: 10.1016/b978-1-4377-1793-8.00086-8] [Reference Citation Analysis]
|
| 419 |
Guarner F. The Enteric Microbiota. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2011;3:1-88. [DOI: 10.4199/c00047ed1v01y201110isp029] [Reference Citation Analysis]
|
| 420 |
Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:94. [PMID: 22162969 DOI: 10.3389/fphys.2011.00094] [Cited by in Crossref: 540] [Cited by in F6Publishing: 572] [Article Influence: 45.0] [Reference Citation Analysis]
|
| 421 |
Cordina C, Shaikh I, Shrestha S, Camilleri-Brennan J. Probiotics in the management of gastrointestinal disease: analysis of the attitudes and prescribing practices of gastroenterologists and surgeons. J Dig Dis 2011;12:489-96. [PMID: 22118700 DOI: 10.1111/j.1751-2980.2011.00534.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 422 |
Quigley EM. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract. 2012;27:195-200. [PMID: 22127952 DOI: 10.1177/0884533611423926] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 423 |
Bron PA, van Baarlen P, Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol. 2011;10:66-78. [PMID: 22101918 DOI: 10.1038/nrmicro2690] [Cited by in Crossref: 421] [Cited by in F6Publishing: 442] [Article Influence: 35.1] [Reference Citation Analysis]
|
| 424 |
Andresen V, Keller J, Pehl C, Schemann M, Preiss J, Layer P. Irritable bowel syndrome--the main recommendations. Dtsch Arztebl Int. 2011;108:751-760. [PMID: 22163251 DOI: 10.3238/arztebl.2011.0751] [Cited by in Crossref: 13] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 425 |
Ringel Y, Ringel-Kulka T. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome. J Clin Gastroenterol 2011;45 Suppl:S145-8. [PMID: 21992954 DOI: 10.1097/MCG.0b013e31822d32d3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 426 |
Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011;141:1782-91. [PMID: 21741921 DOI: 10.1053/j.gastro.2011.06.072] [Cited by in Crossref: 461] [Cited by in F6Publishing: 482] [Article Influence: 38.4] [Reference Citation Analysis]
|
| 427 |
Rao AS, Camilleri M, Eckert DJ, Busciglio I, Burton DD, Ryks M, Wong BS, Lamsam J, Singh R, Zinsmeister AR. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol 2011;301:G919-28. [PMID: 21836056 DOI: 10.1152/ajpgi.00168.2011] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 428 |
Talley NJ, Fodor AA. Bugs, stool, and the irritable bowel syndrome: too much is as bad as too little? Gastroenterology 2011;141:1555-9. [PMID: 21945058 DOI: 10.1053/j.gastro.2011.09.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 429 |
Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011;301:G799-807. [PMID: 21737778 DOI: 10.1152/ajpgi.00154.2011] [Cited by in Crossref: 193] [Cited by in F6Publishing: 181] [Article Influence: 16.1] [Reference Citation Analysis]
|
| 430 |
Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 137] [Cited by in F6Publishing: 143] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 431 |
Quigley EM. Gut microbiota and the role of probiotics in therapy. Curr Opin Pharmacol. 2011;11:593-603. [PMID: 21996283 DOI: 10.1016/j.coph.2011.09.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 432 |
Franz CM, Huch M, Abriouel H, Holzapfel W, Gálvez A. Enterococci as probiotics and their implications in food safety. Int J Food Microbiol 2011;151:125-40. [PMID: 21962867 DOI: 10.1016/j.ijfoodmicro.2011.08.014] [Cited by in Crossref: 435] [Cited by in F6Publishing: 454] [Article Influence: 36.3] [Reference Citation Analysis]
|
| 433 |
Agrawal A, Whorwell P. Treatment of bloating and distension - role of probiotics. Aliment Pharmacol Ther 2011;34:580-1; author reply 581-3. [PMID: 21806643 DOI: 10.1111/j.1365-2036.2011.04766.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 434 |
Caselli M, Vaira G, Calo G, Papini F, Holton J, Vaira D. Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr 2011;2:372-6. [PMID: 22332079 DOI: 10.3945/an.111.000604] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 435 |
Schröder A, Fink P. Functional Somatic Syndromes and Somatoform Disorders in Special Psychosomatic Units: Organizational Aspects and Evidence-Based Treatment. Psychiatric Clinics of North America 2011;34:673-87. [DOI: 10.1016/j.psc.2011.05.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 436 |
Chey WD, Maneerattaporn M, Saad R. Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. Gut Liver 2011;5:253-66. [PMID: 21927652 DOI: 10.5009/gnl.2011.5.3.253] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 437 |
Andrews CN, Griffiths TA, Kaufman J, Vergnolle N, Surette MG, Rioux KP. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2011;34:374-83. [PMID: 21671966 DOI: 10.1111/j.1365-2036.2011.04732.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 438 |
Yoon SS, Sun J. Probiotics, nuclear receptor signaling, and anti-inflammatory pathways. Gastroenterol Res Pract. 2011;2011:971938. [PMID: 21808643 DOI: 10.1155/2011/971938] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 439 |
Verna EC, Lucak S. Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol. 2010;3:307-319. [PMID: 21180611 DOI: 10.1177/1756283x10373814] [Cited by in Crossref: 143] [Cited by in F6Publishing: 150] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 440 |
Sainsbury A, Ford AC. Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol. 2011;4:115-127. [PMID: 21694813 DOI: 10.1177/1756283x10387203] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 441 |
Sanger GJ, Chang L, Bountra C, Houghton LA. Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders. Therap Adv Gastroenterol. 2010;3:291-305. [PMID: 21180610 DOI: 10.1177/1756283X10369922] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 442 |
Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011;17:252-266. [PMID: 21860817 DOI: 10.5056/jnm.2011.17.3.252] [Cited by in Crossref: 122] [Cited by in F6Publishing: 137] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 443 |
Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36:310-340. [PMID: 21777613 DOI: 10.1016/j.neubiorev.2011.07.001] [Cited by in Crossref: 117] [Cited by in F6Publishing: 102] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 444 |
Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol 2011;45:518-25. [PMID: 21436726 DOI: 10.1097/MCG.0b013e31820ca4d6] [Cited by in Crossref: 112] [Cited by in F6Publishing: 110] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 445 |
Quigley EM. Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome. Aliment Pharmacol Ther 2011;34:100-1; author reply 101. [PMID: 21631550 DOI: 10.1111/j.1365-2036.2011.04671.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 446 |
Stanghellini V, Barbara G, Cremon C, Cogliandro R, Antonucci A, Gabusi V, Frisoni C, De Giorgio R, Grasso V, Serra M. Gut microbiota and related diseases: clinical features. Intern Emerg Med. 2010;5 Suppl 1:S57-S63. [PMID: 20865476 DOI: 10.1007/s11739-010-0451-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 447 |
Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 2011;33:1302-10. [PMID: 21507030 DOI: 10.1111/j.1365-2036.2011.04665.x] [Cited by in Crossref: 135] [Cited by in F6Publishing: 133] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 448 |
Larauche M, Mulak A, Taché Y. Stress and visceral pain: from animal models to clinical therapies. Exp Neurol. 2012;233:49-67. [PMID: 21575632 DOI: 10.1016/j.expneurol.2011.04.020.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 449 |
Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381-396. [PMID: 21090962 DOI: 10.1146/annurev-med-012309-103958] [Cited by in Crossref: 315] [Cited by in F6Publishing: 331] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 450 |
Madhwani T, McBain AJ. Bacteriological effects of a Lactobacillus reuteri probiotic on in vitro oral biofilms. Arch Oral Biol 2011;56:1264-73. [PMID: 21570060 DOI: 10.1016/j.archoralbio.2011.04.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 451 |
Larauche M, Mulak A, Taché Y. Stress and visceral pain: from animal models to clinical therapies. Exp Neurol. 2012;233:49-67. [PMID: 21575632 DOI: 10.1016/j.expneurol.2011.04.020] [Cited by in Crossref: 143] [Cited by in F6Publishing: 126] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 452 |
Cabré E. Clinical Nutrition University: Nutrition in the prevention and management of irritable bowel syndrome, constipation and diverticulosis. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 2011;6:e85-95. [DOI: 10.1016/j.eclnm.2011.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 453 |
Pimentel M, Chang C. Inflammation and microflora. Gastroenterol Clin North Am 2011;40:69-85. [PMID: 21333901 DOI: 10.1016/j.gtc.2010.12.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 454 |
Quigley EM. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin North Am 2011;40:207-22. [PMID: 21333908 DOI: 10.1016/j.gtc.2010.12.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 455 |
Bolino CM, Bercik P. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role. Infect Dis Clin North Am. 2010;24:961-975, ix. [PMID: 20937460 DOI: 10.1016/j.idc.2010.07.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 456 |
Cabré E. Irritable bowel syndrome: can nutrient manipulation help? Curr Opin Clin Nutr Metab Care. 2010;13:581-587. [PMID: 20531176 DOI: 10.1097/MCO.0b013e32833b6471] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 457 |
. Clinical Roundup: How Do You Treat Irritable Bowel Syndrome in Your Practice? Alternative and Complementary Therapies 2011;17:50-6. [DOI: 10.1089/act.2011.17110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 458 |
Barbara G. Editorial: toll-like receptor expression in irritable bowel syndrome: on the alert for a microbial threat? Am J Gastroenterol 2011;106:337-9. [PMID: 21301456 DOI: 10.1038/ajg.2010.440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 459 |
Klein M, Sanders ME, Duong T, Young HA. Probiotics: from bench to market. Ann N Y Acad Sci 2010;1212 Suppl 1:E1-14. [PMID: 21105878 DOI: 10.1111/j.1749-6632.2010.05839.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 460 |
Keefer L, Kiebles JL, Taft TH. Psychological Co-morbidities of Irritable Bowel Syndrome. Psychological Co-morbidities of Physical Illness 2011. [DOI: 10.1007/978-1-4419-0029-6_10] [Reference Citation Analysis]
|
| 461 |
Talley N. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life – a double-blind, placebo-controlled study. Yearbook of Gastroenterology 2011;2011:68-69. [DOI: 10.1016/j.ygas.2011.07.133] [Reference Citation Analysis]
|
| 462 |
Talley N. A Randomized Controlled Trial of Lactobacillus GG in Children With Functional Abdominal Pain. Yearbook of Gastroenterology 2011;2011:73-75. [DOI: 10.1016/j.ygas.2011.08.010] [Reference Citation Analysis]
|
| 463 |
Coffin B. Syndrome de l’intestin irritable: traitements conventionnels et alternatifs. Post’U FMC-HGE 2011. [DOI: 10.1007/978-2-8178-0237-4_10] [Reference Citation Analysis]
|
| 464 |
Stevenson C, Blaauw R. Probiotics, with special emphasis on their role in the management of irritable bowel syndrome. South African Journal of Clinical Nutrition 2011;24:63-71. [DOI: 10.1080/16070658.2011.11734353] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 465 |
Deshpande G, Rao S, Patole S. Progress in the field of probiotics: year 2011. Curr Opin Gastroenterol 2011;27:13-8. [PMID: 21712757 DOI: 10.1097/MOG.0b013e328341373e] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 466 |
Fung W, Lye H, Lim T, Kuan C, Liong M. Roles of Probiotic on Gut Health. Probiotics 2011. [DOI: 10.1007/978-3-642-20838-6_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 467 |
Enck P, Junne F, Klosterhalfen S, Zipfel S, Martens U. Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2010;22:1402-11. [PMID: 21389791 DOI: 10.1097/MEG.0b013e3283405a17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 468 |
Szajewska H. The Role of Meta-Analysis in the Evaluation of Clinical Trials on Probiotics. Probiotics and Health Claims 2010. [DOI: 10.1002/9781444329384.ch11] [Reference Citation Analysis]
|
| 469 |
Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun. 2011;25:386-394. [PMID: 21094682 DOI: 10.1016/j.bbi.2010.11.010] [Cited by in Crossref: 198] [Cited by in F6Publishing: 223] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 470 |
Chiou E, Nurko S. Management of functional abdominal pain and irritable bowel syndrome in children and adolescents. Expert Rev Gastroenterol Hepatol. 2010;4:293-304. [PMID: 20528117 DOI: 10.1586/egh.10.28] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 471 |
Ford AC, Moayyedi P, Talley NJ. Irritable Bowel Syndrome. Evidence‐Based Gastroenterology and Hepatology 2010. [DOI: 10.1002/9781444314403.ch21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 472 |
Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 2010;7:503-14. [PMID: 20664519 DOI: 10.1038/nrgastro.2010.117] [Cited by in Crossref: 566] [Cited by in F6Publishing: 560] [Article Influence: 43.5] [Reference Citation Analysis]
|
| 473 |
Marteau P. The clinical importance of intestinal microbiota. Gastroentérologie Clinique et Biologique 2010;34:S93-7. [DOI: 10.1016/s0399-8320(10)70026-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 474 |
Marteau P. L’importance clinique du microbiote intestinal. Gastroentérologie Clinique et Biologique 2010;34:99-103. [DOI: 10.1016/s0399-8320(10)70013-0] [Reference Citation Analysis]
|
| 475 |
Camilleri M, Tack JF. Current medical treatments of dyspepsia and irritable bowel syndrome. Gastroenterol Clin North Am 2010;39:481-93. [PMID: 20951913 DOI: 10.1016/j.gtc.2010.08.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 476 |
Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology. 2010;156:3205-3215. [PMID: 20705664 DOI: 10.1099/mic.0.043257-0] [Cited by in Crossref: 178] [Cited by in F6Publishing: 190] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 477 |
Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M; Asian Neurogastroenterology and Motility Association. Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1189-205. [PMID: 20594245 DOI: 10.1111/j.1440-1746.2010.06353.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 119] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 478 |
Michail S, Stolfi A, Slavin JL. Commentaries on ‘Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood’. Evid -Based Child Health 2010;5:791-795. [DOI: 10.1002/ebch.510] [Reference Citation Analysis]
|
| 479 |
Fujiya M, Kohgo Y. Novel perspectives in probiotic treatment: the efficacy and unveiled mechanisms of the physiological functions. Clin J Gastroenterol 2010;3:117-27. [PMID: 26190117 DOI: 10.1007/s12328-010-0154-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 480 |
Yan F, Polk DB. Probiotics: progress toward novel therapies for intestinal diseases. Curr Opin Gastroenterol 2010;26:95-101. [PMID: 19952741 DOI: 10.1097/MOG.0b013e328335239a] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 481 |
Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010;7:163-73. [PMID: 20101257 DOI: 10.1038/nrgastro.2010.4] [Cited by in Crossref: 399] [Cited by in F6Publishing: 370] [Article Influence: 30.7] [Reference Citation Analysis]
|
| 482 |
Ducrotté P. [Irritable bowel syndrome: dietary and pharmacological therapeutic options]. Gastroenterol Clin Biol 2009;33 Suppl 1:S68-78. [PMID: 19303541 DOI: 10.1016/S0399-8320(09)71527-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 483 |
Layer P. Motilität. Handbuch Gastroenterologie 2010 2010. [DOI: 10.1007/978-3-642-11635-3_9] [Reference Citation Analysis]
|
| 484 |
Camilleri M, Andresen V. Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis 2009;41:854-62. [PMID: 19665953 DOI: 10.1016/j.dld.2009.07.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 485 |
Simrén M. Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead? Therap Adv Gastroenterol 2009;2:5-8. [PMID: 21180549 DOI: 10.1177/1756283X09337569] [Reference Citation Analysis]
|
| 486 |
Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009;6:306-14. [PMID: 19404271 DOI: 10.1038/nrgastro.2009.35] [Cited by in Crossref: 760] [Cited by in F6Publishing: 764] [Article Influence: 54.3] [Reference Citation Analysis]
|
